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ABSTRACT 
  
 This dissertation focuses on radical S-adenosylmethionine enzymes involved in 
cofactor biosynthesis. Mechanistic studies discussed here include: (i) molybdenum 
cofactor biosynthetic enzyme - MoaA, (ii) thiamin pyrimidine synthase – ThiC  (iii) 
hydroxybenzimidazole synthase, HBI synthase, involved in anaerobic vitamin B12 
biosynthesis. 
 MoaA catalyzes the first step in molydopterin biosynthesis where GTP is 
converted to pterin. This catalysis involves a remarkable rearrangement reaction where 
the C8 of guanosine-5’-triphosphate (GTP) is inserted between the C2’ and C3’ carbon 
atoms of GTP to give the final pterin. Mechanistic studies involved characterization of 
the products of the reaction, identification of the position of hydrogen atom abstraction 
by 5’-deoxyadenosyl radical and trapping of intermediates by using 2’,3’-dideoxyGTP, 
2’-deoxyGTP and 2’-chloroGTP as substrate analogs.  
 Thiamin pyrimidine synthase, ThiC, catalyzes a complex rearrangement reaction 
involving the conversion of aminoimidazole ribotide (AIR) to thiamin pyrimidine 
(HMP-P). A hydrogen atom transfer from S-adenosylmethionine (AdoMet) to HMP-P 
was demonstrated. Also, the stereochemistry of this transfer was elucidated.   
 Bioinformatics studies on ThiC revealed that a paralog of ThiC was clustered with 
vitamin B12 biosynthetic genes in several anaerobic microorganisms. The gene 
responsible for the anaerobic vitamin B12 – benzimidazole biosynthesis was previously 
unknown. We demonstrate that the gene product of this ThiC paralog is a radical S-
 	   iii 
adenosylmethionine enzyme. Remarkably it catalyzes the conversion of aminoimidazole 
ribotide (AIR) to 5-hydroxybenzimidazole (5-HBI) and formate, and S-
adenosylmethionine to 5’-deoxyadenosine. We determine the hydrogen atom abstracted 
by 5’-deoxyadenosyl radical. We also performed carbon, nitrogen and hydrogen labeling 
studies and characterized the labeling pattern on 5-HBI. Based on these studies we 
propose a reaction mechanism of this remarkable conversion of AIR to 5-HBI. 
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NOMENCLATURE 
 
AdoMet S-adenosyl-L-methionine 
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GTP guanosine-5’-triphosphate 
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AIR aminoimidazole ribotide 
HMP-P 4-amino-5-hydroxymethyl-2-methylpyrimidine phosphate 
HMP 4-amino-5-hydroxymethyl-2-methylpyrimidine 
5-HB 5-hydroxybenzimidazole 
CO cabon monoxide 
FMN Flavin mononucleotide 
DMB dimethylbenzimidazole 
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CIP Calf intestine phosphatase 
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1. INTRODUCTION TO RADICAL ADOMET ENZYMES 
 
1.1 Introduction to radical S-adenosylmethionine (AdoMet, 1) enzymes 
Complex chemical transformations in biological systems are often radical 
mediated transformations. Some of these transformations commonly include 
rearrangement reactions1, carbon insertion reactions2, radical addition reactions3, 
chemically high energy C-C, C-N, C-P bond fragmentation reactions4-6 and 
epimerization reactions7. These transformations are commonly initiated by hydrogen 
atom abstractions from unactivated C-H bonds to generate radical intermediates, which 
undergo remarkable transformations.  
These radical transformations are mainly catalyzed by cytochrome P450 
dependent enzymes8, non-heme iron containing enzymes9, vitamin B12 containing-
adensyl cobalamin dependent enzymes10 and [4Fe-4S] cluster containing radical S-
adenosylmethionine (AdoMet) enzymes11. 
Radical AdoMet enzymes usually generate a 5’-deoxyadenosyl radical (5’dA 
radical, 2) and L-methionine using a reduced [4Fe-4S]+ cluster and AdoMet. This 5’dA 
radical abstracts a hydrogen atom to form 5’-deoxyadenosine (5’dA) and generates a 
substrate derived radical intermediate (Figure 1.1).  
In contrast to iron(IV)oxo-derived radicals, where the dominant chemistry 
involves radical addition to the iron-bound oxygen, radicals formed by hydrogen atom 
transfer to the adenosyl radical are more persistent because the reverse reaction is 
relatively slow. This allows time for complex rearrangements to occur (Figure 1.1).  
 	   2 
(A) 
 
(B) 
 
Figure 1.1: 5’dA radical mediated chemistry. (A, B) In contrast to radicals 
generated using iron(IV)oxo, radical SAM enzymes generate persistent radicals that can 
undergo complex rearrangements. 
 
Radical AdoMet enzymes catalyze a remarkable range of reactions. This is due to 
the high intrinsic reactivity of organic radicals, which can undergo rapid hydrogen atom 
abstraction, double bond addition and fragmentation reaction (Figure 1.2). Examples of 
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all of these reactions can be found in the radical SAM enzymes used for cofactor 
biosynthesis.  
 
 
 
Figure 1.2: Examples of major reactions found in organic radical 
chemistry. A) Hydrogen atom abstraction reactions. B) Addition to 
double bonds. C-E) β bond scission reactions. 
  
1.2 Diverse rearrangement reactions catalyzed by radical AdoMet enzymes  
Radical AdoMet enzymes catalyze several complex radical rearrangement 
reactions as shown in Figure 1.3.  
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Figure 1.3: Complex radical rearrangement reactions catalyzed by radical 
AdoMet enzymes. (A) Lysine 2,3-aminomutatase catalyzed rearrangement of L-lysine to 
L-beta Lysine. (B) QueE catalyzes the radical mediated ring contraction step (6 to 7) in 
the deazapurine biosynthesis. (C) HydG catalyzes the conversion of tyrosine. (8) to p-
cresol (9), CO (10) and cyaninde. (11) in the H cluster containing FeFe hydrogenase 
maturation. (D) CofG/CofH catalyzed tyrosine (8) and ribityl-daminouracil (12) to Fo in 
the F420 biosynthesis (13). (E) ThiC catalyzed conversion of AIR (14) to HMP-P (15) in 
the prokaryotic thiamin biosynthesis. (F) MoaA-MoaC catalyzed conversion of GTP 
(18) to cPMP (19) in the molybdopterin biosynthesis.  
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Lysine 2,3-aminomutase catalyzes the conversion of L-lysine to L-beta Lysine 
(Figure 1.3A) in the lysine fermenting bacteria.12-15 It was one of the first radical 
AdoMet enzyme to be reconstituted in vitro. QueE catalyzes the radical mediated ring 
contraction step (6) to (7) in the deazapurine biosynthesis.16-19 This step is common to 
the biosynthetic pathways of all deazapurine-containing compounds. HydG catalyzes the 
the conversion of tyrosine (8) to p-cresol (9), CO (10) and cyanide (11) in the H cluster 
containing FeFe hydrogenase maturation.20-24 CofG/CofH catalyzes the conversion of 
tyrosine (8) and ribityl-daminouracil (12) to Fo in the F420 biosynthesis (13).25 ThiC 
catalyzes the conversion of AIR (14) to HMP-P (15) in the prokaryotic thiamin 
biosynthesis.1,26-28 MoaA-MoaC catalyzes the conversion of GTP (18) to cPMP (19) in 
the molybdopterin biosynthesis.2,29-32 MoaA is a radical AdoMet enzyme involved in 
molybdopterin biosynthesis. It uses GTP as a substrate. The product of MoaA was 
unkown before our studies.  
 
1.3 Research opportunity 
It can be seen from the reactions shown in Figure 1.3A-F that Radical AdoMet 
enzymes catalyze several complex radical rearrangement reactions. Mechanistic studies 
have been extensively performed on Lysine 2,3-aminomutase. However, till recently, the 
mechanistic details of reactions B-F (Figure 1.3) were poorly understood.  
This dissertation describes the mechanistic studies on (i) MoaA catalyzed GTP 
transformation in molybdopterin biosynthesis (ii) ThiC catalyzed HMP-P biosynthesis 
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and (iii) ThiC homolog (HBI synthase) catalyzed benzimidazole biosynthesis in the 
anaerobic vitamin B12 biosynthetic pathway.   
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2. MOLYBDOPTERIN BIOSYNTHESIS* 
 
2.1 Introduction to molybdenum cofactor 
Molybdenum is a required nutrient for plants, animals and microorganisms and is 
involved in many redox reactions implicated in the global carbon, sulfur, and nitrogen 
cycles.33,34 With the exception of nitrogenase, all molybdenum requiring enzymes use 
molybdopterin as the metal binding ligand. Nitrate reductase, sulfite oxidase, xanthine 
dehydrogenase and aldehyde oxidase are well known molybdenum cofactor dependent 
enzymes. Molybdopterin forms the core pterin structure of different forms of 
molybdenum cofactor. In humans the deficiency of molybdopterin biosynthetic genes 
leads to death within months of birth.35 Molybdopterin cofactor biosynthetic studies 
have played a critical role in finding the right supplement that overcomes this genetic 
deficiency.36 The genes responsible for molybdopterin biosynthesis have been known 
since 1980s. However, the chemical details of the early steps of this biosynthetic 
pathway were yet to be elucidated.32 
 
 
 
_____________________ 
*Reprinted in part with permission from Mehta, A. P.; Hanes, J. W.; Abdelwahed, S. H.; 
Hilmey, D. G.; Hanzelmann, P.; Begley, T. P. Biochemistry 2013, 52, 1134. Copyright 
2013 American Chemical Society and from Mehta, A. P.; Abdelwahed, S. H.; Xu, H.; 
Begley, T. P. J. Am. Chem. Soc. 2014, 136, 10609. Copyright 2014 American Chemical 
Society and from Mehta, A. P.; Abdelwahed, S. H.; Begley, T. P. J Am Chem Soc 2013, 
135, 10883. Copyright 2013 American Chemical Society. 
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2.2 Background 
The biosynthesis of molybdopterin is similar in plants, animals and microorganisms. The 
biosynthetic pathway is shown in Figure 2.1. The first steps catalyzed by MoaA and 
MoaC use guanosine-5'-triphosphate (1; GTP) as the precursor to synthesize 
cyclicpyranopterin monophosphate (cPMP). The next steps involve the thiolation of 
molydopterin to form 3 followed by the metal incorporation to give 5.32  
 
 
 
 
 
 
Figure 2.1: Molybdopterin biosynthetic pathway. 
 
Previous labeling studies had established that in the conversion of GTP to cPMP 
by MoaA-MoaC, the C8 of GTP is inserted between the C2’ and C3’ carbons as shown 
in the Figure 2.2. This is an unprecedented reaction catalyzed in ribose chemistry.37 
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Figure 2.2: Labeling studies indicating the carbon-insertion reaction 
characterized by MoaA-MoaC. 
 
Also, it was shown that MoaA is a member of the radical-AdoMet superfamily of 
proteins and harbors two [4Fe-4S]2+,1+ clusters. The N-terminal [4Fe-4S] cluster is likely 
to be responsible for the reductive cleavage of AdoMet to the 5’-deoxyadenosyl (5’-dA) 
radical and L-methionine3,4 and the second cluster binds to N1 of GTP.5 A 2.35 Å crystal 
structure of MoaA shows the two clusters at the active site as well as the orientation of 
5’-deoxyadenosine (5’dA) as compared to GTP (Figure 2.3).29-31 
 
 
 
 
 
 
Figure 2.3: MoaA active site. A 2.35 Å crystal structure of MoaA shows the two 
clusters at the active site as well as the orientation of 5’-deoxyadenosine (5’dA) as 
compared to GTP. 
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The crystal structure does not indicate the regiochemistry of hydrogen atom 
abstraction by 5’dA radical. Based on all these previous studies, we decided to 
mechanistically investigate this fascinating reaction catalyzed by MoaA-MoaC. 
 
2.3 Results and discussion 
2.3.1 LCMS analysis of MoaA reaction products – 5’-dA (6) formation 
MoaA assay reactions with GTP, AdoMet and dithionite as reductant were 
incubated in the anaerobic chamber for 3 hrs. The protein was filtered off and the small 
molecule pool was analyzed by LCMS. Figure 2.4 shows the formation and 
characterization of 5’dA formed in the MoaA reaction where all the components were 
present.38  
 
 
Figure 2.4: MoaA reactions – characterization of 5’dA formed. A) HPLC 
analysis of the MoaA reaction mixture. The red trace is from the reaction containing 
MoaA, SAM, GTP and dithionite. The blue, green and pink traces are controls in which 
MoaA, SAM or sodium dithionite were omitted respectively. The peak at 14.5 min is 5’-
dA. All the reactions were performed under anaerobic conditions. B) ESI-MS analysis of 
the 14.5 min peak indicates an m/z of 252.1 Da corresponding to the [M+H] for 5’-dA. 
C) 1H NMR of the 14.5 min peak confirms its identity as 5’-dA. 
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2.3.2 Characterization of MoaA reaction product derived from GTP  
The GTP derived product of the MoaA reaction was also analyzed. This reaction 
product is highly oxygen sensitive, undergoing decomposition to a mixture of products. 
Hence, the MoaA reaction was treated with alkaline phosphatase and it was cleanly 
oxidized using KI/I2 before exposure to air. 38-41 The resulting product was purified by 
HPLC as a fluorescent compound eluting at 17.4 min (Figure 2.5).  
 
 
Figure 2.5: MoaA reactions – characterization of stable oxidized pterin. A) 
MoaA assays with GTP are treated with phosphatase followed by oxidation with KI/I2. 
The HPLC traces show the formation of the fluorescent product eluting at 17.4min. (B) 
UV-Vis spectrum of the product. The UV-Vis spectrum of the compound was similar to 
that of a pterin. (C) The mass spectrum [M+H]+ of the MoaA product shown in the 
HPLC trace in Figure 2.5A. (D) 1H NMR of the purified product. 1,2,3a,b are the signals 
for compound (7), 2e, 3ea,b are the signals for compound (9) and 1’,2’,3’ab are the 
signals for compound (9). x is unknown impurity in the sample. (E) dqfCOSY of the 
purified product. The signals at 3.55ppm and 3.65ppm are glycerol impurities. (F) 
HSQC of the purified product.41 
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(F) 
 
Figure 2.5 Continued. 
  
The UV-Visible spectrum of the purified product shows the characteristic 
features of a pterin (Figure 2.5).42,43 Multiple small- scale MoaA reactions were run to 
give sufficient product for characterization by LCMS and NMR spectroscopy (Figure 
2.5) .41 
 
2.3.3 o-(pentafluorobenzyl) hydroxylamine (PFBHA) derivatization of the 
reaction product 
The oxidized reaction mixture prepared as described above was treated with o-
(pentafluorobenzyl) hydroxylamine (PFBHA) and analyzed for oxime formation by 
LCMS. Figure 2.6 shows the extracted ion chromatograms for 475.1Da which 
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corresponds to the [M+H]+ for the E and Z isomers of compound (10). These were 
absent in controls where MoaA, GTP, AdoMet or dithionite is absent. 
 
(A) 
 
 
 
 
 
(B) 
 
Figure 2.6: Trapping of the ketone-containing MoaA reaction product by oxime 
formation. A) The MoaA reaction mixture was treated with phosphatase, oxidized with 
KI/I2 and converted to the oxime with PFBHA. B) Extracted ion chromatogram of the 
reaction mixture at 475.1Da showing two peaks consistent with a mixture of the E and Z 
isomers of oxime (19) ([M+H]+ of 22(E+Z) = 475.1Da). 
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Figure 2.6A) ([M+H]+ of 22(E+Z) = 475.1Da). This is consistent with pterin (20) as the 
product of MoaA reactions with GTP.41 
 
2.3.4 Reconstitution of MoaA purified from E. coli (MoaC-) strain 
Meanwhile, a study from Kenichi Yokoyama’s lab suggested that (14) was the 
product of MoaA44. In order to exclude the possibility of MoaC contamination in our 
MoaA samples that result in the formation of the pterin, we over-expressed MoaA in a 
MoaC deletion mutant of E. coli. The MoaA reaction product isolated from this strain 
had an identical retention time (Figure 2.7) to the product described in Figure 2.5A. This 
product structure was also confirmed by derivatization with hydroxylamine and LCMS 
analysis (Figure 2.7). 
This provided the first conclusive evidence that pterin (20) was the product of 
MoaA. Thus, we demonstrated that the MoaA catalysis involves a remarkable 
rearrangement reaction where the C8 of GTP is inserted between the C2’ and C3’ carbon 
atoms of GTP to give the final pterin (20). 
This confirms (Figure 2.7) the assignment of pterin as the product of MoaA 
reaction. These studies established that MoaA catalyzes the remarkable carbon insertion 
reaction where GTP is converted to pterin. The next aspect of this study was to 
mechanistically investigate this reaction.41 
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(A) 
 
 
Figure 2.7: Trapping of the ketone-containing MoaA (MoaC-) reaction product. 
(A) HPLC chromatogram of the MoaA reactions carried out using MoaA isolated from a 
MoaC- overexpression strain (Fluorescence: Excitation – 365nm, Emission – 450nm). 
Pink trace: Chromatogram of the reaction mixture generated using MoaA over-expressed 
and purified from E. coli BL21(DE3). Blue trace: HPLC analysis of the reaction mixture 
generated using MoaA over-expressed and purified from E. coli - MoaC- subjected to 
λDE3 lysogenation. The shoulder is a column artifact. Red and green are controls where 
either GTP or MoaA are absent. (B) Trapping of pterin 7, formed using MoaA isolated 
from the MoaC- overexpression strain, with PFBHA.  Extracted ion chromatogram for 
475.1 Da indicating a unique signal in the full reaction for the trapped pterin (10) (B) 
[M+H]+ for the trapped product consistent with structure 10. 
 
 
11" 12" 13" 14" 15" 16" 17" 18"
!me$(min)$
Full"MoaA1deltaMoaC"
Full"MoaA"
No"GTP"1"MoaA1
deltaMoaC"
No"MoaA1deltaMoaC"
!
23.5 24.0 24.5 25.0 25.5 26.0 26.5 27.0 27.5 28.0 Time [min]
-2
0
2
4
6
8
Intens.
[mAU]
Full MoaA_GTP_CIP_KI_PFBHA_pos_1-A,2_01_12043.d: UV Chromatogram, 350 nm No GTP_MoaA_CIP_KI_PFBHA_pos_1-A,4_01_12045.d: UV Chromatogram, 350 nm
No MoaA_GTP_CIP_KI_PFBHA_pos_1-A,3_01_12044.d: UV Chromatogram, 350 nm
+MS, 28.0min #(1652)
0
1000
2000
3000
Intens.
460 465 470 475 480 485 490 m/z
475.1 
476.1 
EIC – 475.1 Da 
-  Full reaction 
-  No GTP 
-  No MoaA (ΔMoaC) 
(A) (B) (B)$ (C)$
 	   16 
2.3.5 5’-dA (6) formation in the MoaA/ deuterated GTP isotopomers 
reactions  
In order to obtain mechanistic insights regarding the MoaA catalyzed 
rearrangement reaction catalyzed by MoaA we wanted to identify the initial site of 
hydrogen abstraction on GTP (1) by the 5’-dA radical (6).  
Several (Table 2.1) site specifically deuterium labeled GMP isotopomers were 
synthesized and converted to GTP in situ using guanylate kinase, nucleoside diphosphate 
kinase and ATP/Mg2+. Deuterium transfer from labeled GTP to the 5’-dA was monitored 
by LCMS (Figure 2.8).  
  
A.  
 
Figure 2.8: Mass spectrometry data for 5’-dA formation with GTP isotopomers. 
(A) MoaA assays with 3’,4’,5’,5’-2H4-GTP (B) MoaA assays with 8’-2H4-GTP (C) 
MoaA assays with 2’-2H4-GTP (D) MoaA assays with U-2H10-GTP (universally 
deuteriated) (E) MoaA assays with 3’-2H4-GTP 
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B.  
 
C.  
 
D.  
 
Figure 2.8 Continued. 
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E.  
 
Figure 2.8 Continued. 
 
Table 2.1: 5’-dA (6) formed in the MoaA reactions with several site-specifically 
deuterated GTP isotopomers. 
Deuterated analogs of GTP LCMS – [M+H]+ for 5’-
deoxyadenosine 
U-2H10-GTP 253.1 
3’,4’,5’,5’-2H4-GTP 253.1 
2’-2H -GTP 252.1 
8-2H –GTP 252.1 
3’-2H -GTP 253.1 
 
Analysis of the 5’-dA generated using universally labeled GTP (i.e. deuterium on 
all non-exchangeable sites) reveled an increase of a single mass unit ([M+H] - 253.1Da) 
demonstrating that only one of the deuterium atoms was incorporated into 5’-dA 
(Table2.1).  No deuterium incorporation was observed with 8-2H-GTP demonstrating 
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that the deuterium was derived from the ribose. No deuterium incorporation was 
observed with 2’-2H-GTP and a single deuterium incorporation was observed with 
3’,4’,5’,5’-2H4-GTP, further localizing the site of deuterium incorporation to C3’, C4’ or 
C5’ of the ribose. Final localization of the hydrogen atom transferred was achieved by 
demonstrating a single deuterium transfer from 3’-2H-GTP to 5’-dA.38 
 
2.3.6 Mechanistic proposal for MoaA catalyzed reaction 
The deuterium labeling studies described above, revealed the site of initial 
hydrogen atom abstraction by 5’dA radical. Based on these studies and the previous 
carbon labeling studies we advanced the first mechanistic proposal for the MoaA 
catalyzed reaction (Figure 2.9).38 
 
 
 
 
 
 
 
 
 
 
Figure 2.9: Mechanistic proposal for MoaA catalyzed reaction.38 
O
HO OH
N
PPPO
N
N N
O
NH2
O
HO OH
N
PPPO
N
N N
O
NH2
H
O
HO OH
N
PPPO
N
N
N
O
NH2
[4Fe - 4S]1+ [4Fe - 4S]
1+
[4Fe - 4S]1+
H2O
O
O OH
N
H
PPPO
H2N
N
N
O
NH2
[4Fe - 4S]2+
O
N
H
H2N
N
N
NH2
[4Fe - 4S]2+OPPPO
OH
HO
O
O N
H
H
N
N
NH
O
NH2
O
HO
PPPO
12
13
15 16
18
20
1
N
H2N
N
N
O
NH2
[4Fe - 4S]2+OHPPPO
HO
O
17
:B
H
O
O
HO OH
N
PPPO
H
N
N
N
O
NH2
[4Fe - 4S]2+
14
Ad
Ad
H
11 6
OH
OH N
H
N
N
N
O
NH2
OH
HO
PPPO
[4Fe - 4S]2+
19
N
H2N
N
N
O
NH2
[4Fe - 4S]2+OHPPPO
HO
O
 	   20 
In this proposal, the 5’-dA radical 11, generated by reductive cleavage of S-
Adenosyl methionine (AdoMet), abstracts the 3’ hydrogen atom from GTP to give 12, 
which then undergoes cyclization to give 13. Reduction of this radical by the purine 
liganded iron sulfur cluster to 14 followed by hydrolysis to 15 and a benzilic like 
rearrangement to 16 completes the insertion of the purine carbon into the ribose. Ring 
opening of 17 followed by dehydration of 18 and  a conjugate addition gives 19. 
Cyclization to 19 followed by a final tautomerization completes the formation of the 
reaction product 203. While ribose and deoxyribose radicals have been extensively 
studied in the context of enzymes such as ribonucleotide reductase and DNA damage by 
radiation or radical-generating antibiotics, addition of a C3’ centered radical to C8 of a 
purine has never been reported5,6,7. The successful trapping of an analog of 15 would 
provide a critical test of the proposed mechanism. 
 
2.3.7 MoaA reactions with 2’,3’-dideoxyGTP – LCMS analysis45 
The successful trapping of an analog of 14 would provide a critical test of the 
proposed mechanism. It can be seen from the above mechanistic proposal that the 
hydroxyl groups at the 2’ and 3’ positions of GTP may play an important role in the 
conversion of GTP to pterin. With the goal to trap an early step intermediate, we decided 
to test 2’,3’-dideoxyGTP 21 as a substrate for MoaA reactions. MoaA reactions with 
2’,3’-dideoxyGTP were analyzed by LCMS as shown in Figure 2.10 
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 Figure 2.10: Analysis of the product formed when 2’,3’-dideoxyGTP 21 is 
treated with MoaA.  A) LC analysis of the MoaA reaction mixture and controls. Red 
trace is the full reaction where all the components are present. Green, pink, black and 
blue traces are for reaction mixtures where either 2’,3’-dideoxyGTP, dithionite, SAM or 
MoaA is  absent respectively. The unidentified signal at 19.9 min has the same [M+H]+ 
as 2’,3’-dideoxyGTP.  B) MS of the compound eluting at 19.6 min.  The [M+H]+ is 
490.0 Da - two Da less than the [M+H]+ of the substrate 21. 
   
LCMS analysis of the MoaA/2’,3’-dideoxyGTP 21 reaction mixture 
demonstrated the formation of a new product eluting at 19.6 min (Figure 2.10). ESI-MS 
(positive mode) analysis of this product demonstrated that its mass [M+H]+ was 490.0 
Da - two Da less than the [M+H]+ of the substrate. We considered two possible 
structures for this product (23 and 27, Figure 2.11). To test for the formation of 23, the 
enzymatic product was dephosphorylated by phosphatase treatment and compared by 
LCMS to an authentic synthesized sample of 24.   
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Figure 2.11: Mechanistic analysis to suggest possible products formed from 
2’,3’-dideoxyGTP (21). 
  
2.3.8 MoaA reactions with 2’,3’-dideoxyGTP – product characterization45 
Figures 2.12A-C demonstrate that the retention time of 24 and its MS/MS 
spectrum are different from the enzymatic product. The MS/MS spectrum of 17 showed 
fragmentation of the N-glycosyl bond to form guanine (152.0 Da, Figure 2.12). This 
fragmentation was not detected for the dephosphorylated enzymatic product (Figure 
2.12) suggesting an additional bond between the sugar and the base consistent with 28. 
This excludes the possibility that MoaA catalyzes the formation of 23 from 21. 
Unfortunately, NMR characterization of the enzymatic product (Figure 2.12) was 
not possible. Only small quantities were formed because 2’,3’-dideoxyGTP 21 is a poor 
substrate (there is no evidence for enzyme modification by MS analysis). An 
identification strategy, involving comparison with a reference compound, was therefore 
adopted. If 26 is the product structure, oxidation and dephosphorylation, followed by N-
glycosyl bond cleavage would give 29 which can be synthesized as a reference. 
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Figure 2.12: MoaA reactions with 2’,3’-dideoxyGTP - product comparison with 
reference standard (24). (A) Product comparison with reference standard 24. Extracted 
Ion Chromatograms for [M+H]+ = 250.0Da demonstrate that compound 24 is different 
from the dephosphorylated enzymatic product. (B) MS/MS of the synthetic reference 
standard for compound 24. (C) MS/MS of the dephosphorylated enzymatic product.  
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To test this, the enzymatic product was derivatized by treating the MoaA reaction 
mixture with phosphatase followed by acid at 65oC for 2 hrs. The extracted ion 
chromatograms for 268.1Da (29 + H+ + H2O) are shown in Figure 2.13 and demonstrate 
that the acid treatment generates isomers of the product as expected from ring opening of 
the hemiacetal. The derivatized enzymatic product coelutes with the synthetic reference, 
(also generates isomers on acid treatment) and is identical by LCMS analysis. Thus, the 
enzymatic reaction of 2’,3’-dideoxy-GTP, 21 supports the formation of the remarkable 
reaction intermediate 14 in the MoaA-catalyzed reaction. 
  
 
 Figure 2.13: MoaA reactions with 2’,3’-dideoxyGTP – hydrolyzed product 
comparison with reference standard (29). A) Extracted Ion Chromatograms for [M+H]+ 
= 268.1 Da demonstrate that the [M+H]+ = 268.1Da signal is seen only in reaction 
mixtures with all the components present after phosphatase treatment and acid 
hydrolysis. The two compounds with [M+H]+ = 268.1Da are most likely a consequence 
of hemiacetal isomerization during the acid hydrolysis.  B) MS of the compound formed 
by acid hydrolysis of the dephosphorylated enzymatic product ([M+H]+ = 268.1 Da).  C) 
Extracted Ion Chromatograms for [M+H]+ = 268.1Da demonstrate that the derivatized 
enzymatic product has the same mass and co-elutes with compound 29.  
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A mechanistic proposal for the formation of 29/30, is described in Figure 2.14. 
The 5’-dA radical 11 abstracts the 3’ hydrogen atom from 2’,3’-dideoxyGTP 21, to give 
22, which then undergoes cyclization to give 25. Reduction of this radical by the purine 
liganded iron sulfur cluster gives 26 which on aerobic oxidation results in the formation 
of 27. Phosphatase treatment of 27 followed by acid hydrolysis gives 29/30 as a mixture 
of isomers. 
 
 
 
 
 
 
 
 
 
Figure 2.14: Mechanistic proposal for the product formed in the MoaA catalyzed 
reaction with 2’,3’-dideoxyGTP and subsequent derivatization. 
 
2.3.9 MoaA reactions 2’-chloroGTP – HPLC and LCMS analysis41 
We next explored the use of 2’-chloroGTP (31) to trap radical (12, Figure 2.9). 
This strategy was previously developed to study the radical intermediates formed by 
ribonucleotide reductase, DNA irradiation, and by radical-generating antibiotics.46-48 
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LCMS and HPLC analysis of the MoaA/2’-chloroGTP reaction mixture 
demonstrated the formation of a new compound eluting at 3 minutes and identified as 
guanine (32) by comparison with an authentic standard (Figure 2.15). Pterin was not 
detected in the reaction mixture.  
 
 
Figure 2.15: MoaA reactions with 2’-chloroGTP – product characterization. (A) 
The MoaA-catalyzed reaction of 2’-chloroGTP (31) results in the formation of guanine 
(32) and furanone (33). (B) LCMS traces to confirm the formation of guanine as one of 
the product. (C) Analysis of the MoaA-catalyzed reaction of 2’-chloroGTP (31) for the 
ribose derived product. The reaction mixture was treated with phosphatase followed by 
3-mercaptobenzoic acid to yield (33). (D) The chromatograms are extracted ion 
chromatogram – 249.0 Da corresponding to the [M-H]- of (35). Co-injection shows that 
that the 3-mercaptobenzoic acid derivative of the enzymatic product is identical to (35) 
by LCMS analysis.  
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The ribose-derived product (33) was trapped by treating the reaction mixture 
with 3’-mercaptobenzoic acid. The extracted ion chromatogram for [M-H]-=249.0 Da 
corresponded to the [M-H]- of compound (35), the expected trapped product. An 
authentic standard of compound (35) was synthesized (Figure 2.15) and found to be 
identical by LCMS analysis to the trapped product. 
A mechanistic proposal for this reaction is shown in Figure 2.16.  We also tested 
the 2’-chloroGTP isomer where the 2’-chloro was in the S orientation as a substrate 
analog. No reaction was observed. 
 
 
 
 
 
 
 
 
 
 
Figure 2.16: Mechanism of the MoaA-catalyzed reaction of 2’-chloroGTP (31).  
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2.3.10 MoaA reactions with 2’-deoxyGTP – LCMS analysis41 
 Next, we wanted to investigate the conversion of 15 to 16, which involves the 
carbon insertion step. There are two possible mechanistic proposals for this step as 
shown in the Figure 2.17. 
 
 
 Figure 2.17: The two possible mechanistic proposals for the carbon insertion 
step. (A) involves the hydroxyl group at 3’ position and (B) involves the hydroxyl group 
at 2’ position. 
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the reaction. The proposal in Figure 2.9 suggests that this compound might block the 
conversion of (14) to (20) and that any trapped species would elucidate the later steps in 
the MoaA-catalyzed reaction. 
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was treated with alkaline phosphatase and analyzed by HPLC. In order to collect 
sufficient product, multiple reactions were run. A fluorescent product was observed at 
(A)$
(B)$
O
O OH
N
H
PPPO
H2N
N
N
OH
NH2
[4Fe - 4S]2+
O
:B
H
N
H
H2N
N
N
NH2
[4Fe - 4S]2+OPPPO
OH
HO
O
OH
O
HO O
N
H
PPPO
H2N
N
N
OH
NH2
[4Fe - 4S]2+
O
:B
N
H
H2N
N
N
NH2
[4Fe - 4S]2+OPPPO
O
HO
HO
OH
H
15 16
15 39
 	   29 
excitation wavelength of 365nm and an emission wavelength of 450nm. The UV-Vis 
spectrum of the compound was similar to that of a pterin.42,43 Oxidation with KI/I2 was 
not necessary to stabilize this reaction product.   LCMS analysis revealed an [M+H]+ =  
268.1 Da. The UV-Vis spectrum and LCMS experiments suggested that structures (40) 
or (41) with undetermined stereochemistry at the site of initial hydrogen atom 
abstraction. To resolve this, we synthesized both isomers and compared them with the 
enzymatic product by HPLC. This analysis demonstrated that the reaction product has 
the stereochemistry shown in (40) (Figure 2.18).  
 
 
Figure 2.18: MoaA reactions with 2’-deoxyGTP (42b) – product 
characterization. (A) The HPLC chromatograms (Fluorescence – Excitation -365nm and 
emission – 450nm) show that a unique signal is seen only in the full reaction and not in 
the controls where either of MoaA, GTP, AdoMet or dithionite are absent. (B) [M+H]+ 
of the unique signal in the full reaction. (C) HPLC co-injection experiment to determine 
the stereochemistry at the purine derived carbon of the product. 
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The stereochemistry at C2 of the 2,3,4-trihydroxybutyl substituent is assumed to 
be the same as that in the starting 2’-deoxy-GTP because this center does not participate 
in the reaction (Figure 2.9). The S-stereochemistry at C3 (the site of initial hydrogen 
atom abstraction) was determined by HPLC comparison of the enzymatic product with 
synthetic standard (Figure 2.18C). This suggests that the formation of (40) is primarily 
or exclusively occurring at the MoaA active site because non-enzymatic chemistry 
would result in the scrambling of stereochemistry at C3 of the pterin substituent. The 
formation of (40) is not consistent with the proposed conversion of (14) to (20) shown in 
Figure 2.9. A revised mechanistic proposal for the MoaA-catalyzed reaction is outlined 
in Figure 2.19. 
 
2.3.11 Revised mechanistic proposal for MoaA-catalyzed reaction41 
When 2’-deoxyGTP (42b) is used as a substrate, we propose that (47b), formed 
as shown in Figures 2.9 and Figure 2.19, undergoes ring opening, tautomerization (50b). 
Conjugate addition followed by a double tautomerization would give (57). Loss of water 
and a final tautomerization would give the observed enzymatic product (40). For the 
native MoaA-catalyzed reaction, using GTP as the substrate (42a, X=OH), hydrogen 
atom abstraction from C3’ of GTP gives radical (43a) which then adds to C8 of the 
purine to give (44a). Electron transfer from the purine liganded [4Fe-4S] cluster gives 
(45a). Aminal hydrolysis to (46a) followed by a benzylic-like rearrangement gives 
(47a). Ring opening followed by tautomerization gives (50a), which is converted to (20) 
by a conjugate addition, water elimination, tautomerization and a final ring closure. 
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Figure 2.19: Revised mechanistic proposal for the MoaA-catalyzed reaction. 
MoaA –catalyzed conversion of GTP (42a) (also 1) to (20) and 2’-deoxyGTP (42b) to 
(40). 
 
This mechanism (Figure 2.19) is consistent with the regiochemistry of hydrogen 
atom abstraction by the 5’-deoxyadenosyl radical, with the trapping of (14) directly or 
using 2’,3’-dideoxyGTP, the trapping of radical (43a) using 2’Cl-GTP and the 
conversion of 2’-deoxyGTP to (40).  
 
2.4 Conclusion 
We reconstituted MoaA-catalyzed transformation. MoaA catalyzes the first step 
in molydopterin biosynthesis where GTP is converted to pterin (20). This catalysis 
involves a remarkable rearrangement reaction where the C8 of guanosine-5’-
triphosphate (GTP) is inserted between the C2’ and C3’ carbon atoms of GTP to give the 
final pterin. We characterized the reaction products and identification of the position of 
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hydrogen atom abstraction by 5’-deoxyadenosyl radical. Based on this we put forth the 
first mechanistic proposal for MoaA catalyzed reaction (Figure 2.9).  
An independent study from Kenichi Yokoyama’s lab suggested that 45a was the 
product of MoaA. We expressed MoaA in E. coli (MoaC-) and showed that in our hands, 
pterin was the product of MoaA. We did not see any accumulation of 45a in our 
assays.41 This provided the first conclusive evidence that pterin (20) was the product of 
MoaA. Thus, we demonstrated that MoaA catalysis involves a remarkable 
rearrangement reaction where the C8 of GTP is inserted between the C2’ and C3’ carbon 
atoms of GTP to give the final pterin (20). 
 We used 2’,3’-dideoxyGTP as a substrate analog and trapped a novel 
intermediate (27). This intermediate provided critical evidence in support of our first 
mechanistic proposal. We further trapped the radical (43a, also 12) by using 2’-
chloroGTP (31). We characterized the products of MoaA reaction with 2’-chloroGTP.  
We decided to explore the use of 2’-deoxyGTP (42b) to probe the later steps of 
the reaction. MoaA reaction with 2’-deoxyGTP resulted in the formation of a stero-
specific product (40). This suggested that the formation of (40) was primarily or 
exclusively occurring at the MoaA active site because non-enzymatic chemistry would 
result in the scrambling of stereochemistry at C3 of the pterin substituent. The formation 
of (40) was not consistent with the proposed conversion of (14) to (20) shown in Figure 
2.9. This study clarified the later step of MoaA-catalyzed transformation. Based on this 
we revised our mechanistic proposal for the MoaA-catalyzed reaction (as outlined in 
Figure 2.19).  
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2.5 Experimental 
2.5.1 Overexpression and purification of MoaA38 
The MoaA overexpression plasmid was previously described1. MoaA was co-
expressed in the presence of a plasmid encoding the suf operon for in vivo [4Fe-4S] 
reconstitution E. coli BL21 (DE3). An overnight 15 ml culture was grown in LB media 
in the presence of ampicillin and chloramphenicol.  This was then added to 1.5 L of LB 
media containing ampicillin and chloramphenicol. The cultures were incubated at 370C 
with shaking (180 rpm) until the OD600 reached 0.45. The culture was then incubated at 
40C without shaking for 1.5 hrs. Then 200 mg of ferrous ammonium sulfate and 200 mg 
of cysteine were added. This was followed by induction of the culture with 100 µM 
IPTG. The culture was then incubated at 150C with shaking (110 rpm) for 14 - 16hrs. 
The culture was then incubated at 40C for 3 hrs without shaking. The cells were then 
harvested and stored in liquid nitrogen overnight before enzyme purification. For 
enzyme purification, the cell pellets were thawed at room temperature in an anaerobic 
chamber and suspended in lysis buffer (100 mM Tris-HCl, pH 7.5) in the presence of 
2mM DTT, lysozyme (0.2 mg/ml) and benzonase (100 units).  This mixture was then 
cooled in an ice-bath for 2 hrs. The suspension of cells was then sonicated and 
centrifuged to give the cell-free extract. The enzyme was then purified using standard 
Ni-NTA chromatography. The column was first incubated with the lysis buffer. The cell-
free extract was then passed over the column, which was then washed with 5-6 column 
volumes of wash buffer (100 mM Tris-HCl, 300 mM NaCl, 20 mM imidazole, 2mM 
DTT, pH 7.5). The protein was then eluted using 100 mM Tris-HCl, 300 mM NaCl, 250 
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mM imidazole, 2 mM DTT, pH 7.5. The purified enzyme was buffer exchanged into 100 
mM potassium phosphate, 30% glycerol, 2 mM DTT, pH 7.5 using a 10DG column and 
the purified enzyme was stored in liquid nitrogen. 
 
2.5.2 Overexpression and purification of guanylate kinase49 
The guanylate kinase overexpression plasmid was transformed into E. coli BL21 
(DE3). An overnight 15ml culture was grown in LB media in the presence of ampicillin. 
This was then added to 1.5L of LB media containing ampicillin. The cultures were 
incubated at 370C with shaking (180 rpm) until the OD600 reached 0.55. This was 
followed by induction of the culture with 100 µM IPTG at 150C for 14hrs at 180rpm. 
The enzyme was purified on a blue sepharose column prepared in wash buffer (15 mM 
Tris-HCl, 1 mM EDTA, 1 mM DTT). The column was loaded with cell free extract, 
washed with wash buffer until the OD280 was less than 0.02. The enzyme was then eluted 
with 15 mM Tris-HCl, 1 mM EDTA, 1 mM DTT, 5 mM GMP. 
 
2.5.3 Enzymatic assays for MoaA reactions for LCMS characterization of 
5’dA (6)38 
 The enzymatic reaction mixtures contained MoaA (125 µM), GTP (1 mM), SAM 
(1.5 mM), and sodium dithionite (in excess) and were incubated at room temperature in 
an anaerobic chamber for 3 hrs. For HPLC and LCMS analysis the enzyme was removed 
by ultrafiltration using a 10kDa cut-off filter. The samples were then prepared in the 
anaerobic chamber and sealed before HPLC or LCMS analysis.  
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 For a reaction mixture using a GMP isotopomer as substrate, guanylate kinase 
(20µM), NDP kinase (20µM), ATP (5 mM), MgCl2 (2 mM), MoaA (125  µM) and GMP 
(1 mM) were incubated at room temperature for 10 mins. SAM (1.5mM) and sodium 
dithionite (in excess) were then added and the reactions were run as described above. 
 
2.5.4 Enzymatic assays for MoaA reactions for LCMS/NMR 
characterization of pterin (8)41 
The reaction mixture consisted of 250µM MoaA, 2mM GTP, 3mM AdoMet and 
10mM dithionite and was incubated in an anaerobic chamber for 5h at room 
temperature. The protein was then removed by ultrafiltration using a 10kDa cut-off 
filter. The resulting small molecule pool was treated with 3µl of alkaline phosphatases in 
the presence of 1mM MgCl2, incubated in the anaerobic chamber for an additional 3h 
and quenched with 100µl of oxygen-free KI/I2 (5% I2 (w/v) and 10% KI (w/v) in water). 
38-40 The reaction was analyzed by LCMS. For NMR characterization, the reaction 
mixture was purified by HPLC. The fluorescent product eluting at 17min (Figure 2.5) 
was collected and dried using a vacuum centrifuge. Several such reaction mixtures were 
purified to yield sufficient product for NMR characterization. The dried samples were 
dissolved in 250µl of a 90%:10% H2O/D2O mixture and analyzed by NMR (Bruker, 
500MHz).  
MoaA reactions were also performed with MoaA over-expressed and purified 
from the E. coli-MoaC deletion strain. An identical fluorescent compound eluting at 
17min was observed (Figure 2.7).  
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2.5.5 MoaA over-expressed and purified from E. coli (MoaC-)41 
The E. coli - MoaC deletion strain was obtained from CGSC, Yale and rendered 
compatible with a pET vector using a λDE3 lysogenation kit. MoaA was over-expressed 
in this strain and purified. Reaction with GTP yielded a product that was derivatized by 
treatment with alkaline phosphatase and KI/I2. This fluorescent product was identical by 
HPLC analysis with the product produced by MoaA isolated from the MoaC+ strain 
(Figure 2.7). 
 
 2.5.6 PFBHA derivatization of the reaction product41 
 The reaction mixture consisted of 250µM MoaA, 2mM GTP, AdoMet and 
10mM dithionite and was incubated in an anaerobic chamber for 5h. The protein was 
then removed by ultrafiltration using a 10kDa cut-off filter. The resulting small molecule 
pool was treated with 3µl of alkaline phosphatase in the presence of 1mM MgCl2, 
incubated in the anaerobic chamber for an additional 3h and quenched with 100µl of 
oxygen free KI/I2 (5% I2 (w/v) and 10% KI (w/v) in water).38-40 PFBHA (100µl of 
40mM) was then added, the mixture was heated at 65OC for 1.5h and analyzed by 
LCMS. Control reactions, lacking MoaA, GTP, SAM or dithionite were also run and 
similarly analyzed. 
 
2.5.7 Assay conditions for MoaA reactions with 2’,3’-dideoxyGTP (21) 45 
 The enzymatic reaction mixtures contained MoaA (125 µM), 2’,3’-dideoxyGTP 
(1.8 mM), S-Adenosyl methionine (AdoMet) (2.7 mM), and sodium dithionite (10mM) 
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and were incubated at room temperature in an anaerobic chamber for 3 hrs. Controls 
were set up where either MoaA, AdoMet, dithionite or 2’,3’-dideoxyGTP was missing. 
For HPLC and LCMS analysis the enzyme was removed by ultrafiltration using a 10kDa 
cut-off filter. 
 
2.5.8 Phosphatase treatment of MoaA/2’,3’-dideoxyGTP reaction mixtures45  
Calf intestinal phosphatase (CIP) was purchased from New England Biolabs. 
MoaA reactions were set up as described above. From the 200µl of the reaction 
mixtures, the enzyme was removed by ultrafiltration using a 10kDa cut-off filter. The 
reaction mixtures were stored aerobically for 2 hrs before CIP treatment. Then 5µl of 
1M NaOH was added to each of the assays so that the pH of the reaction mixture was 
7.5-8. 2µl of 1M MgCl2 and 400 units of CIP were the added. The reaction mixtures 
were incubated at 37oC for 3.5 hrs. CIP was removed by ultrafiltration using a 10 kDa 
cut-off filter. 
 
2.5.9 Acid hydrolysis of phosphatase treated MoaA/2’,3’-dideoxyGTP 
reaction mixtures45 
MoaA assays with 2’,3’-dideoxyGTP were set up and dephosphorylated as 
described above. CIP was separated from the small molecule pool by using 10kDa cut 
off filters. 1M HCl was added to the above reaction mixture to make the final 
concentration of HCl to 0.5M. The reactions were incubated at 65oC for 2 hrs. The 
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reactions were then cooled to room temperature and then neutralized by NaOH. The 
neutralized assays were then analyzed by LCMS. 
 
 2.5.10 Assay conditions for MoaA reactions with 2’-chloroGTP (21) for 
guanine characterization41 
 2’-chloroGMP (3mM) was synthesized and phosphorylated using NDP kinase 
(100 units), guanylate kinase (50µM) and ATP (10mM). Guanylate kinase was over-
expressed and purified as described earlier.38 This crude reaction mixture was used as a 
source of 2’-chloroGTP. For the MoaA-catalyzed reaction, 250µM MoaA, 2mM 2’-
chloroGTP, 3mM AdoMet and 10mM dithionite were mixed and incubated in the 
anaerobic chamber for 5h. Controls were set up for this reaction where either MoaA, 
AdoMet, dithionite or NDP kinase/Guanylate kinase were absent. The small molecule 
pool was analyzed by LCMS.  
 
2.5.11 Assay conditions for MoaA reactions with 2’-chloroGTP (21) for 
trapping of ribose derived product41 
For the trapping of the reactive 2’-Cl-ribose-derived product, all the above 
reactions were performed in DTT free buffer. 50µl of the small molecule pool were 
treated with 3µL of alkaline phosphatase followed by 3-mercaptobenzoic acid (50µl of 
100mM solution) at 700C for 1hr. 
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2.5.12 MoaA reactions with 2’-deoxyGTP (42b)41 
 MoaA (250µM), 2mM 2’-deoxyGTP, 3mM AdoMet and 10mM dithionite were 
mixed and incubated in the anaerobic chamber for 5h at room temperature. Controls 
were also set up in which MoaA, 2’-deoxyGTP, AdoMet or dithionite were absent. The 
protein was removed by ultrafiltration using a 10kDa cut-off filter. The small molecule 
pool was treated with 3µl of alkaline phosphatases in the presence of 1mM MgCl2 and 
incubated in the anaerobic chamber for 3h. The reaction mixture was analyzed by LCMS 
and the product was purified by reverse phase HPLC. The isolated product was 
concentrated using a vacuum centrifuge. For the co-elution experiment 100µM stock 
solutions of compounds (40) and (41) were made. Standards (50µl) and 50µl of the 
concentrated product were mixed and analyzed by HPLC. 
 
2.5.13 LCMS conditions for MoaA reactions for LCMS characterization of 
5’dA (6)38 
LC-ESI-TOF-MS analysis was performed using an Agilent 1260 HPLC system 
equipped with a binary pump and autosampler and a 1200 diode array detector upstream 
of a MicroToF-Q II mass spectrometer (Bruker Daltonics, Billerica, MA) using the ESI 
source in positive ionization mode. LC conditions: A – 20mM N,N-dimethylhexylamine, 
10mM ammonium acetate, pH 6.4 B – 75% methanol, 25% water 
Column – Agilent Poroshell 120, EC-C18, 2.7µm, 3x10mm LC method: 0 min – 100% 
A, 5 mins – 100% A, 15 mins - 60% A 40% B, 27 mins – 10% A 90% B, 36min – 100% 
A. MS parameters: Capillary, -4500 V; Capillary offset, -500 V; Nebulizer gas, 3.0 bar; 
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Dry gas, 10.0 L/min; Dry gas temperature, 200oC; Funnel 1 RF, 200.0 Vpp; Funnel 2 
RF, 250.0 Vpp; ISCID, 0.0 eV; Hexapole RF, 150 Vpp; Quadrapole, Ion energy, 5.0 eV; 
Low mass, 80 m/z; Collision cell, collision energy, 10.0 eV; Collision RF, 150.0 Vpp, 
Transfer time, 100.0 µs; Prepulse storage, 5.0 µs. Data was processed with DataAnalysis 
ver. 4.0 SP4 (Bruker Daltonics, Billerica, MA) 
 
2.5.14 HPLC conditions for the purification of 5’-dA formed in the MoaA 
reactions38 
Agilent 1260 HPLC was used with a fraction collector for the purification of both 5’-dA 
and compound Z. LC-18-T column (3.0 x 150 mm, 3 µm, Supelco) was used for the 
purification. Chromatography conditions were as follows: A: water B: 5mM ammonium 
formate pH 6.6 C: methanol. HPLC method: 0 min – 100%B, 4 mins- 10%A 90%B, 9 
mins – 25%A 60%B 15%C, 14 min – 25%A 10%B 65%C, 17 mins – 100% B, 24 mins 
– 100%A. 
 
2.5.15 LCMS characterization of the dephosphorylated product of MoaA 
reactions with GTP and hydroxylamine derivatized product (10)41 
LC conditions: A – 5mM ammonium acetate, pH 6.7 B – 75% methanol, 25% 
water. Column – Agilent Poroshell 120, EC-C18, 2.7µm, 3x10mm LC method: 0 min – 
100% A, 7 mins – 100% A, 15 mins - 80% A 20% B, 20 mins – 70%A 30%B, 26 mins – 
0% A 100% B, 28 min – 0% A 100%B, 29 min – 100%A MS parameters: Capillary, -
4500 V; Capillary offset, -500 V; Nebulizer gas, 3.0 bar; Dry gas, 10.0 L/min; Dry gas 
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temperature, 200oC; Funnel 1 RF, 200.0 Vpp; Funnel 2 RF, 250.0 Vpp; ISCID, 0.0 eV; 
Hexapole RF, 200 Vpp; Quadrapole, Ion energy, 5.0 eV; Low mass, 150 m/z; Collision 
cell, collision energy, 10.0 eV; Collision RF, 150.0 Vpp, Transfer time, 100.0 µs; 
Prepulse storage, 5.0 µs. Data was processed with DataAnalysis ver. 4.0 SP4 (Bruker 
Daltonics, Billerica, MA). 
 
2.5.16 HPLC purification of the MoaA/GTP reaction product41 
HPLC -1260 series Agilent. LC-18 column -  ((Supelcosil SPLC-18 column 
(25cm x 10mm, 5µm)). Following gradient was used - A:water, B: 5mM ammonium 
formate, C: methanol. 0 min: 100%B, 7 min: 10%A 90%B, 12 min: 25%A 60%B 15%C, 
17 min: 25%A 10%B 65%C, 19 min-29min: 100%B) 
 
2.5.17 LCMS parameters for the product detection of MoaA reactions with 
2’,3’-dideoxyGTP45 
LC-ESI-TOF-MS analysis was performed using an Agilent 1260 HPLC system 
equipped with a binary pump and autosampler and a 1200 diode array detector upstream 
of a MicroToF-Q II mass spectrometer (Bruker Daltonics, Billerica, MA) using the ESI 
source in positive ionization mode. LC conditions: A – 20mM N,N-dimethylhexylamine, 
10mM ammonium acetate, pH 6.4 B – 75% methanol, 25% water Column – Agilent 
Poroshell 120, EC-C18, 2.7µm, 3x10mm LC method: 0 min – 100% A, 5 mins – 100% 
A, 15 mins - 60% A 40% B, 27 mins – 10% A 90% B, 36min – 100% A. MS parameters 
are the same as those described in 2.4.13. 
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2.5.18 LCMS parameters for comparing the dephosphorylated, acid 
hydrolyzed product of MoaA with 2’,3’-dideoxyGTP with reference standards45 
LC conditions: A – 5mM ammonium acetate, pH 6.7 B – 75% methanol, 25% water 
Column – Agilent Poroshell 120, EC-C18, 2.7µm, 3x10mm LC method: 0 min – 100% 
A, 7 mins – 100% A, 15 mins - 80% A 20% B, 20 mins – 70%A 30%B, 26 mins – 0% A 
100% B, 28 min – 0% A 100%B, 29 min – 100%A MS parameters: Capillary, -4500 V; 
Capillary offset, -500 V; Nebulizer gas, 3.0 bar; Dry gas, 10.0 L/min; Dry gas 
temperature, 200oC; Funnel 1 RF, 200.0 Vpp; Funnel 2 RF, 200.0 Vpp; ISCID, 0.0 eV; 
Hexapole RF, 200 Vpp; Quadrapole, Ion energy, 5.0 eV; Low mass, 100 m/z; Collision 
cell, collision energy, 10.0 eV; Collision RF, 150.0 Vpp, Transfer time, 100.0 µs; 
Prepulse storage, 5.0 µs. Data was processed with DataAnalysis ver. 4.0 SP4 (Bruker 
Daltonics, Billerica, MA). 
 
2.5.19 LCMS conditions for MoaA assays with 2’-chloroGTP – detection of 
guanine41 
Following gradient was used - A – 10mM N,N-dimethylhexyamine, pH 6.4 B – 
75% methanol, 25% water, Column – Agilent Poroshell 120, EC-C18, 2.7µm, 3x10mm. 
0 min – 100% A, 5 mins – 100% A, 15 mins - 60% A 40% B, 27 mins – 10% A 90% B, 
36min – 100% A. MS parameters are the same as those described in 1.4.18. 
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2.5.20 LCMS conditions for MoaA assays with 2’-chloroGTP – detection of 
3-mercaptobenzoic acid derivatized product 
1200 series Agilent (binary pump) LC conditions were as follows: A – 5mM 
ammonium acetate, pH 6.7, B – 75% methanol, 25% water. Reverse phase column – 
Supelcosil LC18, 3µm, 3x10mm. The gradient was as follows: 0 min – 100% A, 7 mins 
– 100% A, 15 mins - 80% A 20% B, 20 mins – 70%A 30%B, 26 mins – 0% A 100% B, 
28 min – 0% A 100%B, 29 min – 100%A MS parameters are the same as those 
described in 1.4.18. 
 
2.5.21 LC conditions for MoaA assays with 2’-deoxyGTP – product isolation 
and co-elution experiment41 
HPLC (Supelcosil SPLC-18 column (25cm x 10mm, 5µm)). Conditions were as 
follows: A: water, B: 5mM ammonium formate, C: methanol. 0 min : 100%B, 7min : 
10%A 90%B, 12 min: 25%A 60%B 15%C, 17min : 25%A 10%A 65%B, 19min-29min: 
100%B. The LCMS conditions are the same as those described in 1.4.18. 
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2.5.22 Synthesis scheme for guanosine-5’-monophosphate  (65) 
The synthetic scheme for GMP is shown in Figure 2.20. 
 
 
 Figure 2.20: Synthetic scheme for GMP (65). 
 
2.5.23 Synthesis of [2-2H] and [2-2H] 1,2,3,5-tetra-O-acetylribofuranoside 
(62) 
Dowex 8 × 50W, 200–400, H+ cation-exchange resin (300 mg) was washed with 
anhydrous methanol and then stirred for 4.5 h at room temperature with ribose  (260 mg, 
1.72 mmol) in anhydrous methanol (6 mL). Reaction was monitored by TLC (CHCl3: 
MeOH, 85:15) for completion. The resin was removed by filtration and washed with 
anhydrous methanol. The combined filtrate and washings were evaporated to give 1-O-
methyl- ribofuranoside which was dissolved in anhydrous pyridine (5 mL) and cold in 
ice bath then treated with acetic anhydride (0.5 mL, 564 mg, 5.48 mmol) and stirred at 
room temperature for 4 h. The reaction mixture was cooled (ice-bath), diluted with water 
59# 60# 61# 62#
63#64#65#
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(25 mL) and the resultant aqueous solution was extracted with chloroform (4 × 25 mL). 
The combined organic extracts were washed with water (4 × 50 mL), dried and then co-
evaporated with toluene to give 1-O-methyl-2,3,5-tri-O-acetyl-ribofuranoside which was 
subjected to next reaction without further purification. A cooled (ice-bath) solution of 1-
O-methyl-2,3,5-tri-O-acetyl-ribofuranoside (403 mg, 1.39 mmol) and acetic anhydride 
(1.4 mL, 1.56 g, 15.16 mmol) in glacial acetic acid (10 mL) was treated drop-wise with 
conc. sulfuric acid (0.2mL) and then stirred at room temperature for 3 h. The reaction 
mixture was cooled (ice-bath) and ice (10 g) was added with continued stirring. When 
the ice had melted, the resultant aqueous solution was extracted with chloroform (4 × 25 
mL). The combined organic extracts were washed successively with water (2 × 50 mL), 
a saturated aqueous solution of sodium bicarbonate (2 × 50 mL) and water (50 mL), then 
dried and evaporated to give 1,2,3,5-tetra-O-acetyl-ribofuranoside (355 mg, 80%) as a 
virtually colorless oil which solidified after standing at room temperature. [2-2H] 
tetraacetyl ribofuranose:1H NMR (CDCl3) δ 6.41 (d, 0.3, H1α), 6.15 (s, 0.7, H1β), 5.3 
(d, 0.7, H3β), 5.2 (d, 0.3, H3 α), 4.1–4.5 (m, 3, H4, H5, H5’) 2.10 (s, 3, CH3CO), 2.07 
(s, 3, CH3CO), 2.06 (s, 3, CH3CO), 2.04 (s, 3, CH3CO). [3-2H] tetraacetyl ribofuranose: 
1H NMR (CDCl3) δ 6.41 (d, 0.3, H1 α), 6.15 (s, 0.7, H1β), 5.2–5.3 (m, 1, H2), 4.1–4.5 
(m, 3, H4, H5, H5’), 2.10 (s, 3, CH3CO), 2.08 (s, 3, CH3CO), 2.06 (s, 3, CH3CO), 2.04 
(s, 3, CH3CO). 
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2.5.24 Synthesis of 2-acetylamino-2' ,3' ,5' –tri-O-acetyl-6-O-(N,N-
diphenylcarbamoy)-guanosine (63) 
2-acetylamino-6-O-diphenylcarbamoylguanine (220 mg, 0.63 mmol) was 
suspended in 1,2-dichloroethane (6.5 ml) under nitrogen and treated with N,O-bis-
(trimethylsilyl)-acetamide (0.32 ml). The mixture was heated to 80°C and stirred for 15 
min when some of the suspension dissolved. The solvents were removed in vacuo. The 
residue was suspended in dry benzene (3 ml) under nitrogen and fresh 
trimethylsilyltrifluoromethanesulfonate (150 uL) was added. 1,2,3,5-tetra-O-acetyl-D-
ribofuranose (200 mg, 0.62 mmol) dissolved dry benzene (3 ml) was added to the 
mixture which was heated to 80°C for 1 h. The solution was diluted with ethyl acetate, 
washed with water and brine and dried (MgSO4). The solvent was removed in vacuo to 
yield a yellow foam, which was absorbed onto silica gel and purified by column 
chromatography on silica gel using hexanes : ethyl acetate  (1:1) as eluent. This 
procedure was followed to get both the [2-2H] labeled and [3-2H] labeled compounds. 
 
2.5.25 Synthesis of guanosine (64) 
2-acetylamino-2',3',5'-tri-O-acetyl-6-O-(N,N-diphenylcarbamoyl)-guanine  (180 
mg, 0.28 mmo1) was dissolved in methanol (3 ml). 1N aqueous ammonium hydroxide 
was added until turbidity. After stirring overnight at 4oC, the solvents were removed in 
vacuo and the residue was recrystallised from water as an off-white solid. This 
procedure was followed to get both the [2-2H] labeled and [3-2H] labeled. 
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2.5.26 Synthesis of guanosine-5’-monophosphate (65, GMP) 
A suspension of guanosine  (50 mg, 0.177 mmol) in TEP, trimethylphosphate, 
(0.6 mL) was heated at 50oC for 15 min and then cooled to 0oC. Water (1.59 uL, 0.0885 
mmol) was added followed by POCl3 (33uL, 0.354 mmol) at 0oC, and the entire mixture 
was further stirred at 0oC for 1.5 h. The mixture was poured into ice-water (1 mL) and 
stirred for another hour before it neutralized by ammonium bicarbonate solution. The 
reaction mixture was lyophilized to give white product which then purified by Prep 
HPLC using a SPLC-18DB column (10 x 250 mm, 5 µ, Supelco) at a flow rate of 2 
mL/min using an Agilent 100 HPLC system with quaternary pump and manual injector. 
This procedure was followed to get both the [2-2H] labeled and [3-2H] labeled guanosine 
 
2.5.27 HPLC conditions for purification of GMP isotopomers 
Agilent 1260 HPLC was used with a fraction collector for the purification of both 
5’-dA and compound Z. LC-18-T column (3.0 x 150 mm, 3 µm, Supelco) was used for 
the purification. Chromatography conditions were as follows: A: water B: 5mM 
ammonium formate pH 6.6 C: methanol 0 min – 100%B, 7 mins- 10%A 90%B, 12 mins 
– 25%A 60%B 15%C, 17 min – 25%A 10%B 65%C, 19 mins – 100% B, 30 mins – 
100%A. 
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2.5.28 Synthesis of [8-2H] guanosine-5’-monophosphate 38 
8-2H- GMP was synthesized by H/D exchange with D2O. GMP was heated at 
800C in D2O and the completion of the reaction was monitered by NMR. 
Dr. Sameh H. Abdelwahed synthesized 2’-2H-GMP and 3’-2H-GMP. 
 
2.5.29 Synthetic scheme for 2’,3’-anhydro-2’,3’-dideoxyguanosine (24) 
The synthetic scheme for 24 is shown in Figure 2.21. 
 
 
Figure 2.21: Synthetic scheme for  2’,3’-anhydro-2’,3’-dideoxyguanosine (24). 
 
2.5.30 Synthesis of 2’,3’-anhydro-2’,3’-dideoxyguanosine (24) 
Methanesulfonyl chloride (550µL, 7.1 mmoles) was added dropwise to a solution 
of 600mg. (2.2 mmoles) of 2'-deoxyguanosine (66) in 10 ml. of dry pyridine which, had 
been chilled previously to - 100C. After 3 hrs at 0oC, the reaction mixture was treated 
with 5ml. of water and the solution poured slowly with vigorous stirring into ice-water. 
The mesylated compound precipitates out. This solid was dried and used for the next 
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step. A solution of 320mg. (0.75 mmoles) of 31 in 15 ml. of water containing 2.2 ml. of 
1.055 M sodium hydroxide was refluxed for 2 hrs. The cooled solution was neutralized 
with acetic acid and evaporated to dryness. The dry residue was further purified by silica 
gel flash chromatography. The compound 68 was analyzed by NMR and ESI-MS. 
1HNMR (300 MHz, CD3OD): 2.8 (m, H-2’, H-2’), 2.7, 3.2 (s, CH3- OMs), 4.3 (m, H-5’), 
4.86 (m, H-4’), 5.6 (m, H-3’), 6.4 (t, H-1’), 7.9 (s, H-8). 
Conversion of compound 68 to 2’,3’-anhydro-2’,3’-dideoxyguanosine 24: 
Purified compound 31 (40mg, 0.16mmoles) was added to 1ml of DMSO containing. 
22mg (0.196 mmoles) of t-BuOK in 2 ml. of DMSO was added to the above mixture. 
The mixture was stirred at 25oC for 2 hrs and then neutralized with a dilute solution of 
acetic acid and evaporated to dryness.  
The product 24 was then extracted with chloroform, purified by silica gel flash 
chromatography (CH3Cl:MeOH – 10:1) and analyzed by NMR and ESI-MS. 1H NMR 
(300 MHz, CD3OD): 4.2, 4.3 (d, H-5’), 6.1 (d, H-1’), 6.3 (m, H-2’), 6.4 (m, H-3’), 7.8 (s, 
H-8). The 4’-H predicted under water signal5. 
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2.5.31 Synthetic scheme for 2-amino-8-((3S)-5-hydroxy-2-
(hydroxymethyl)tetrahydrofuran-3-yl)-9H-purin-6-ol (29)45 
The synthetic scheme for 29 is shown in Figure 2.22. This reference standard 
(29) was synthesized by Dr. Sameh H. Abdelwahed. 
 
 
Figure 2.22: Synthetic scheme for 2-amino-8-((3S)-5-hydroxy-2-
(hydroxymethyl)tetrahydrofuran-3-yl)-9H-purin-6-ol (29). 
 
2.5.32 Synthesis of methyl-6-O-(tert-butyldimethylsilyl))-α-D-
glucopyranoside (70) 
 To a stirred solution of commercially available methyl-α-D-glucopyranoside (69) 
(5 g, 25.74 mmol) in 40 ml of dry pyridine was slowly added tert-butyldimethylsilyl 
chloride (3.88, 25.74 mmol) and the mixture was kept for overnight at room temperature. 
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After removal of the solvent under reduced pressure, the residue was taken up in ethyl 
acetate and extracted with 0.5 M HCl, saturated aqueous NaHCO3 and brine. The 
aqueous layers were re-extracted twice with ethyl acetate and the combined organic 
layers were dried over MgSO4. After evaporation of the solvent and drying of the 
product in vacuo, the residue was purified by flash column chromatography (hexane/ 
ethyl acetate, 3:1) yielding the silylether 24 (5.1 g, 65%) as a white solid, 1H NMR (300 
MHz, CD3OD): 0.05 (s, 6H), 0.91 (s, 9H), 3.29 (m, 2H), 3.38 (s, 3H), 3.49 (m, 1H), 3.60 
(m, 1H), 3.75 (m, 1H), 3.87 (m, 1H), 4.63 (d, J = 3.7 Hz, 1H) 
 
2.5.33 Synthesis of methyl-2,3-anhydro-6-O-( tert-butyldimethylsilyl)-α-D-
allopyranoside (71) 
Compound 70 (4.0 g, 12.98 mmol) and triphenylphosphine (4.25 g, 16.21 mmol) 
were dissolved in 80 ml of benzene (dried using sodium metal).  Diisopropyl 
azodicarboxylate (2.8 ml, 14.27 mmol) was added dropwise over a period of 30 min at 
room temperature. The mixture was stirred for 1 hr at room temperature and then 
refluxed for 4 hrs. After washing with 0.5 N HCl and with brine, the aqueous layers were 
twice re-extracted with ethyl acetate and the combined organic layers were dried over 
MgSO4. After filtration and removal of the solvents under reduced pressure, the residue 
was purified by flash column chromatography (hexane/ ethyl acetate, 3:1) yielding 3.1 g 
71 (83%) 1H NMR (300 MHz, CDCl3): 0.01 (s, 6H), 0.85 (s, 9H), 3.44 (s, 3H), 3.47 (m, 
1H), 3.50 (m, 1H), 3.60 (m, 1H), 3.72 (m, 1H), 3.86 (m, 2H), 3.93 (d, J = 8.7, 1H). 
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2.5.34 Synthesis of (2S,5S)-2-(tert-butyldimethyl silanyloxymethyl)-5-
methoxy-2,5-dihydrofuran-3- carbaldehyde (72) 
 A mixture of lithium bromide (3.8 g, 44.5 mmol) and tetramethylurea (4.5 ml) in 
160 ml of toluene was refluxed in a Dean-Stark apparatus while a solution of the epoxide 
71 (3.0 g, 10.34 mmol) in 90 ml of toluene was added dropwise over 3 hrs.  The reaction 
mixture was then refluxed for another 1 hr. After removal of the solvents under reduced 
pressure, hexane (50 ml) was added and the crude reaction mixture was filtered through 
a plug of celite. The filtrate was concentrated under reduced pressure und purified by 
flash column chromatography (hexane/ethyl acetate, 3:1) yielding 2.1 g (75%) of 
aldehyde 72. 1H NMR (300 MHz, CDCl3): -0.03 (s, 3H), 0.01 (s, 3H), 0.80 (s, 9H), 3.41 
(s, 3H), 3.86 (m, 2H), 5.12 (m, 1H), 5.89 (d, J =4.3 Hz, 1H), 6.66 (d, J = 1.8 Hz, 1H), 
9.85 (s, 1H). 
 
2.5.35 Synthesis of (2S,3R/S, 5S)-2-(tert-butyldimethyl silanyloxymethyl)- 5-
methoxytetrahydrofuran-3- carbaldehyde (73) 
(2S,5S)-2-(tert-butyldimethylsilanyloxymethyl)-5-methoxy-2,5-dihydrofuran-3-
carbaldehyde (72, 2.1 gm) was dissolved in toluene (100 ml) and hydrogenated (H2, 
Pd/C, 100 mg, 10%)  after 30 min the solvent was filtered through a plug of celite and 
evaporated, the residue was chromatographed on silica-gel (hexane/ ethyl acetate, 3:1) to 
yield a quantitative amount 0.7:1.0 mixture of S/R epimers of the corresponding 
aldehyde 73. 1H NMR (300 MHz, CD3OD): 0.03 (4s, 6H), 0.83 (2s, 9H), 2.22 (m, 1H), 
2.3 (m, 1H), 2.82 (m, 1H), 3.29, 3.33 (2s, 3H), 3.59-3.83 (m, 3H), 5.04, 4.92 (m, 1H), 
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9.62, 9.71 (2d, 1H). The R and the S isomers were distinguished from each other by 
NOESY. The NMR signals for the R and the S isomers were as follows: R-isomer 1H 
NMR (400 MHz, CDCl3): -0.01 (s, 3H), -0.007 (s, 3H), 0.81 ( s, 9H), 1.92 (dd, JAB = 
13.3 Hz, J= 8.5 Hz, 1H), 2.33 (ddd, JAB = 13.3 Hz, J= 8.1 Hz, 5.0 Hz, 1H), 3.2 (m, 1H), 
3.27 (s, 3H), 3.72 (m, 2H), 4.38 (ddd, J= 8.6 Hz, 4.7 Hz, 3.4 Hz 1H), 5.07(d, J= 5.0 Hz, 
2.15 Hz, 1H). S-isomer 1H NMR (400 MHz, CDCl3): 0.006 (s, 3H), 0.01 (s, 3H), 0.83 ( 
s, 9H), 2.16 (m, 2H), 2.8 (m, 1H), 3.22 (s, 3H), 3.67 (m, 2H), 4.32 (q, J= 4.3 Hz, 1H), 
4.98 (dd, J= 3.8 Hz, 1.9 Hz, 1H). The characteristic feature of the two isomers is the 
proton signal at C4 of compound 73. In case of the R isomer, the NMR signals for the 
protons on C4 are separated from each other by 0.5ppm. In case of S isomer these 
signals overlap. This feature will be useful while assigning the stereochemistry of 
compound 75. 
 
2.5.36 Synthesis of 2-amino-8-((2S, 3R/S, 5S)-2-(tert-butyldimethyl 
silanyloxymethyl)-5-methoxytetrahydrofuran-3-yl)-9H-purin-6-ol (74) 
2,5,6-triaminopyrimidin-4-ol  (110 mg, 0.78 mmol) was dissolved in DMSO (1.5 
ml).  A solution of 73 (180 mg, 0.66 mmol) in 0.5 ml of DMSO was added dropwise 
over 3 min. and the reaction mixture was heated to 80oC for 4 hrs. After evaporation of 
the solvent and drying of the product in vacuo, the residue was chromatographed on 
silica-gel (hexane/ ethyl acetate, 1:1) to yield 155 mg (60%) of 74 as a white solid, 
which was used in the next reaction without further purification. 
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 2.5.37 Synthesis of 2-amino-8-((2S, 3S,5S)-2-(hydroxymethyl)-5-
methoxytetrahydrofuran-3-yl)-9H-purin-6-ol (75) 
 Compound 74 (100 mg, 0.25 mmol) was dissolved in dry tetrahydrofuran (5 ml). 
Tetrabutylammonium fluoride (1.0 M in THF, 0.5 ml) was added to this solution at room 
temperature. After 10 min, TLC analysis indicated that the reaction was complete. The 
solvent was removed under reduced pressure and the product was dried in vacuo, the 
residue was chromatographed on silica-gel (hexane/ ethyl acetate, 1:1) to give the 
corresponding purine 54 mg (76%). 1H NMR (300 MHz, D2O): 2.31 (m, 1H), 2.72 (m, 
1H), 2.75 (m, 1H), 3.49 (2s, 3H), 3.86 (m, 2H), 4.52 (m, 1H), 5.41(m, 1H). The NMR 
signals for protons at C4 are separated by around 0.5 ppm. This is similar to the R 
isomer of compound 73. By this analogy we confirm the stereochemistry at C3 of 
compound 75. 
 
2.5.38 Synthesis of 2-amino-8-(( 3S)-5-hydroxy-2-
(hydroxymethyl)tetrahydrofuran-3-yl)-9H-purin-6-ol (29) 
10 mg of compound 29 was dissolved in 0.5N HCl and heated to 65oC for 2 hrs. The 
solvent was removed under reduced pressure and the product was dried in vacuum to 
give a mixture of isomers of compound 22 (compounds 22a, 22b, 22c, 22d). 1H NMR 
(400 MHz, D2O): 1.9-2.5 (m, H-4), 3.5- 4.2 (m, H-1, H-2, H-3), 4.86, 5.4, 5.57 (m, H-5). 
The acid deprotection reaction generates isomers of the product 29. One set of isomers 
could be the α and β isomers at C5. The other isomer could be the pyranose from of 
compound 29 (compound 30 shown in Figure 2.14). The enzymatic N-glycosyl bond 
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hydrolysis reaction for conversion of compound 28 to compound 29 (shown in Figure 
2.14) is carried out under identical conditions mentioned above. These synthesized set of 
isomers co-elute with the enzymatically-generated products during LCMS analysis.  
 
2.5.39 Synthetic scheme for 2’-chloroGMP (81)41 
The synthetic scheme for (81) is shown in Figure 2.23. Dr. Sameh H. 
Abdelwahed synthesized (81). 
 
 
Figure 2.23: Synthetic scheme for 2’-chloroGMP (81) 
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2.5.40 Synthesis of 9-(3ʹ′,5ʹ′-O-(1,1ʹ′,3,3ʹ′-tetraisopropyldisiloxane-1,3-diyl)-β-
D-arabinofuranosyl) guanine (77) 
Treatment of 0.44 g (0.80 mmol) of 3`,5`-O-(1,1`,3,3`-tetraisopropyldisiloxane-
1,3-diyl)-α-D-guanosine (76) with 2.3 equiv of  Dess-Martin periodinane reagent, gave 
0.4 g of a yellow glass whose 1H NMR spectrum (DMSO-d6) indicated formation of the 
2`-ketoguanosine derivative plus its hydrate. Reduction of this material with sodium 
borohydride afforded 9-(3`,5`-O-(1,1`,3,3`-tetraisopropyldisiloxane-1,3-diyl) 
arabinofuranosy1)guanine which was purified by flash column chromatography 
(chloroform/methanol 5%). Yield 0.3 g (68%). 1H NMR (DMSO-d6) ppm 10.6 (s, NH 
amide), 7.7 (s, H8), 6.5 (s, NH2), 5.95 (d, H1ʹ′), 5.82 (d, OH), 4.35 (t, H2ʹ′), 4.25 (m, 
H3ʹ′), 4.1 (d, H4ʹ′), 3.95 (dd, H5ʹ′ and H5ʹ′ʹ′), 1.00 [m, Si-­‐CH(CH3)2 and CH3]. ESI MS of 
77: calculated for C22H39N5O6Si2 525.2, observed 526.2 m/z ([M+H]+). 
 
2.5.41 Synthesis of 9-(3`,5`-O-(1,1`,3,3`-tetraisopropyldisiloxane-1,3-diyl) )-
2ʹ′-O-[(trifluoromethyl)sulfonyl] arabinofuranosyl)guanine (78)  
A solution of 77 (0.27 g, 0.52 mmol) and 4-(dimethylamino)pyridine (0.13 g, 1.5 
mmol) in pyridine (0.4 mL, 4.6 mmol)-­‐dichloromethane  (10 mL) was cooled to 0 °C (1 
h) and treated with trifluoromethanesulfonic anhydride (0.13 mL, 0.77 mmol). The 
mixture was stirred at 0 °C for 5 min and then at room temperature for 3 h and finally 
partitioned between dichloromethane (10 mL) and water (10 mL). The organic layer was 
washed with water (2 x	  20 mL), brine (2 x	  20 mL) and finally dried over magnesium 
sulfate. Flash column chromatography (Hexane /ethylacetate 15%) yielded 78: 0.2 g 
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(60%). 1H NMR (CDCl3) ppm 11.9 (s, NH amide), 7.8 (s, H8), 6.15 (bs, NH2), 6.15 (d, 
H1ʹ′), 5.3 (t, H2ʹ′), 4.82 (m, H3ʹ′), 3.9-4.1(m, H4ʹ′, H5ʹ′ and H5ʹ′ʹ′), 1.00 [m, Si-­‐CH(CH3)2 
and CH3]. ESI MS of 78: calculated for C23H38F3N5O8SSi2 657.2, observed 658.2 m/z 
([M+H]+). 
 
2.5.42 Synthesis of 3ʹ′ ,5ʹ′-O-(1,1ʹ′ ,3,3ʹ′-tetraisopropyldisiloxane- 1,3-diyl)-2ʹ′-
chloro-­‐2ʹ′-deoxy-β-D-guanosine (79) 
The trifluoromethanesulfonate 54 (0.2 g, 0.3 mmol) and lithium chloride  (0.13 g, 
0.3 mmol)  were dissolved in 10 mL of dimethylformamide (DMF) and the solution was 
stirred at 50oC for 30 min, then cooled to room temperature and stirred overnight at 
room temperature. The reaction was monitored by TLC in chloroform/methanol (10:1). 
After removal of the solvent under reduced pressure, the residue was taken up in 
ethylacetate and washed with water. The aqueous phase were re-extracted twice with 
ethylacetate and the combined organic phase was dried over magnesium sulfate. After 
evaporation of the solvent and drying of the product under vacuum, the residue was 
purified by flash column chromatography (Hexane/ethylacetate 15%) yielding 79: 0.1 g 
(60%). 1H NMR (CDCl3) ppm 11.9 (bs, NH amide), 7.8 (s, H8), 6.3 (bs, NH2), 6.12 (s, 
H1ʹ′), 4.65 (m, H3ʹ′ and H4ʹ′), 4.1-4.25 (m, H2ʹ′, H5ʹ′ and H5ʹ′ʹ′), 1.10 [m, Si-­‐CH(CH3)2 and 
CH3]. ESI MS of 79: calculated for C22H38ClN5O5Si2 543.2, observed 544.2m/z 
([M+H]+) 
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2.5.43 Synthesis of 2’-chloro-2’-anhydroguanosine (80) 
Deprotection of the bifunctional silyl group: a 1 molar solution of tetra-n-
butylammonium fluoride (2eq) was added to a solution of 79 in tetrahydrofuran (THF) at 
room temperature and the deprotection reaction was followed by TLC (CHCl3: MeOH, 
5:1). The reaction was almost completed within 10 min. The reaction mixture was then 
concentrated under reduced pressure and the residue was purified by flash column 
chromatograpfy (chloroform/methanol 5%). 1H NMR (MeOD, d4) ppm 8.02 (s, H8), 
6.13 (d, H1ʹ′), 4.91 (m, H3ʹ′), 4.43 (m, H4ʹ′), 4.2 (m, H2ʹ′), 3.8 (m, H5ʹ′ and H5ʹ′ʹ′). 
 
2.5.44 Synthesis of 2’-chloro-2’-anhydroguanosine-5’-monophosphate (81) 
A suspension of 2'-chloro-2'-deoxyguanosine, 56 (50 mg, 0.177 mmol) in 
trimethylphosphate, (0.6 mL) was heated at 50oC for 15 min and then cooled to 0oC. 
Water (1.6 uL, 0.09 mmol) was added followed by POCl3 (33uL, 0.35 mmol) at 0oC, and 
the entire mixture was further stirred at 0oC for 1.5 h. The mixture was poured into ice-
water (1 mL) and stirred for another hour before it was neutralized with ammonium 
bicarbonate solution. The reaction mixture was lyophilized to give white product which 
was then purified by Prep HPLC using a SPLC-18DB column (10 x 250 mm, 5 µ, 
Supelco) at a flow rate of 2 mL/min using an Agilent 100 HPLC system with a 
quaternary pump and manual injector. 1H NMR (D2O) ppm 8.1 (s, H8), 6.25 (s, H1ʹ′), 
4.55 (m, H3` and H4ʹ′), 4.3 (m, H2ʹ′), 4.0 (m, H5ʹ′ and H5ʹ′ʹ′). 
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2.5.45 Synthetic scheme for 5-(3-mercaptobenzoic acid)-3-furanone (35)41 
The synthetic scheme for (35) is shown in Figure 2.24. This reference standard 
(35) was synthesized by Dr. Sameh H. Abdelwahed. 
 
 Figure 2.24: Synthetic scheme for 5-(3-mercaptobenzoic acid)-3-furanone (35). 
  
2.5.46 Synthesis of 5′-O-tosylthymidine (83) 
Tosylthymidine was prepared accodring to the literature procedure7 and is 
summarized as follows. Briefly, thymidine (2.0 mmol) was treated with a 1.2 equivalents 
of p-TsCl in 15 mL dry pyridine at −5 °C. After 16 h at 0 °C, the reaction was quenched 
with ice−water and extracted with chloroform. The combined chloroform extracts were 
washed consecutively with saturated NaHCO3 and water and dried over anhydrous 
MgSO4. Flash chromatography on silica (methanol/chloroform 5%) yielded pure 5′-O-
tosyl thymidine in 56% yields. 1H NMR (MeOD) ppm 7.83 (d, HA), 7.51 (s, HT), 7.74 (d, 
HB), 6.25 (t, H1`), 4.33 (m, H4`), 4.41 (m, H5`and H5``), 2.47 (s, CH3), 2.26 (m, CH2), 
1.90 (s, CH3). 
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2.5.47 Synthesis of 3′-keto-5′-tosylthymidine (84) 
Compound 83 was oxidized by the Dess-Martin method A cold (0 oC) solution of 
tosylthymidine (0.5 g, 1.26 mmol) in DMF (5 ml) was added to a solution of the Dess-
Martin periodinane reagent (0.55 g, 1.3 mmol) in DMF (5 ml) at 0oC. Stirring was 
continued for 15 min at 0 oC and 3 h at ambient temperature. The solvent was removed 
by vacuo at ambient temperature, the solid crude material was dissolved in ethanol (50 
ml) and filtered. The solvent was evaporated in vacuo at ambient temperature to give 84 
(0.42 g, 85 %; ~ 95% purity). 1HNMR (acetone-d6) ppm 7.80 (d, HA), 7.52 (s, HT), 7.45 
(d, HB), 6.25 (dd, H1`), 4.33-4.43 (m, H4`, H5`and H5``), 2.46 (s, CH3), 1.85 (s, CH3). 
 
2.4.48 Synthesis of 2-methylene-3(2H)-furanone (33) 
Generation of 60 was catalyzed by the addition of 5 uL of triethylamine to 15 mg 
(0.038 mmol) of 3`-keto-5`-tosylthymidine in 0.5 mL of acetone-d6,  1HNMR (acetone-
d6) ppm 8.47 (d, H1`, J = 2.42 Hz), 5.93 (d, H2`, J = 2.4 Hz), 5.49 (d, H5`, J = 2.0 Hz), 
5.30 (d, H5``, J = 2.0 Hz) 
 
2.5.49 Synthesis of 5-(3-mercaptobenzoic acid)-3-furanone (35) 
3′-keto-5′-tosylthymidine (100 mg, 0.25 mmol) was dissolved in 2.0 mL of 
chloroform, and 10 uL of purified triethylamine was added. After 10 min at room 
temperature, (48 mg, 0.3 mmol) of 3-mercaptobenzoic acid and 20 uL of triethylamine 
were added. The solvent was evaporated in vacuo at ambient temperature to give a crude 
material that was purified by silica gel column chromatography in (methanol : 
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chloroform 5-10%). It was noticed that there is only one compound formed and isolated 
even if 3-mercaptobenzoic acid was added in excess. 1HNMR (CDC13) ppm 8.51 (d, 
H1`), 8.26 (s, HA), 8.00 (d, HD), 7.76 (d, HB), 7.44 (t, HC), 5.77 (d, H2′), 4.58 (dd, H4′), 
3.57 (dd, H5′), 3.23 (dd, H5′′). 
 
2.5.50 Synthetic scheme for 2-amino-6-((2S/2R,3S)-2,3,4-
trihydroxybutyl)pteridin-4(3H)-one (40, 41)41 
The synthetic scheme for (41) is shown in Figure 2.25. 
 
 
 Figure 2.25: Synthetic scheme for 2-amino-6-((2S/2R,3S)-2,3,4-
trihydroxybutyl)pteridin-4(3H)-one (40, 41). 
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2.5.51 Synthesis of (2R,3S,4R,5R)-2-((p-toluidino)methyl)-tetrahydro-2H-
pyran-2,3,4,5-tetraol (87) 
Glacial acetic acid (30µL) was added to a mixture of d-glucose (1.08 g, 6mmol), 
p-toluidine (772 mg, 7 mmol) in water (1 mL). The mixture was rotated on a rotary 
evaporator (sealed without vacuum) at 90°C for 2 h (during this time the product 
precipitated from the reaction mixture). After cooling to room temperature, ether–
ethanol (3:1, 20 mL) was added. Upon stirring at room temperature for an additional 2 h, 
the mixture was filtered, washed with ether (10 mL), ether–ethanol (5:1, 20 ml mL), 
ether (10 mL), and dried under vacuum to give aminoalcohol 87 as a 
light brownish white solid (0.6 g, 41%). 1H NMR (DMSO-d6) ) ppm 6.88 (d, 2H), 6.55 
(d, 2H), 5.44 (s, 1H), 4.85 (m, 1H), 4.36 ( m, 3H), 3.85 (d, 1H), 3.66-3.55 (m, 3H), 3.48 
(d, 1H), 3.27 (dd, 1H), 2.99 (dd, 1H), 2.14 (s, 3H) 
 
2.5.52 Synthesis of 2-amino-6-((2S,3S)-2,3,4-trihydroxybutyl)pteridin-4(3H)-
one (40) 
A mixture of 2,5,6-triaminopyrimidin-4-ol (210 mg, 1.5 mmol), p-tolyl-D-
isoglucosamine (198 mg, 0.73), sodium acetate (225 mg) and boric acid (60 mg) in water 
(5 ml) was heated in a stream of argon for 6 h on a water bath. A grayish brown solid 
separated out. The product was filtered and washed with acetone (20 mL) and ethanol till 
the filtrate was colorless. This was followed by an ether wash. The buff colored solid 
was dissolved in 1N HCl (30 ml). The solution was treated with charcoal and filtered. 
The resulting filtrate was neutralized with ammonia and the neutralized solution was left 
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in the cold room overnight. This resulted in a yellow precipitate, (0.11 g, 56%). 1H 
NMR (DMSO-d6) ) ppm 8.28 (s, 1H), 6.90 (bs, 2H), 4.66 (m, 2H), 4.38 (bs, 1H), 3.83, 
3.76 (2bs, 1H), 3.45 (m, 1H), 3.39 (m, 2H), 3.12 (m, 1H), 2.81 (m, 1H). 
 
2.5.53 Synthesis of (2R,3S,4R,5R)-2-((p-toluidino)methyl)-tetrahydro-2H-
pyran-2,3,4,5-tetraol (90) 
Glacial acetic acid (30µL) was added to a mixture of d-glucose (1.08 g, 6mmol), 
p-toluidine (772 mg, 7 mmol) in water (1 mL). The mixture was rotated on a rotary 
evaporator (sealed without vacuum) at 90°C for 2 h (during this time the product 
precipitated from the reaction mixture). After cooling to room temperature, ether–
ethanol (3:1, 20 mL) was added. Upon stirring at room temperature for an additional 2 h, 
the mixture was filtered, washed with ether (10 mL), ether–ethanol (5:1, 20 ml mL), 
ether (10 mL), and dried under vacuum to give aminoalcohol 90 as a light brownish-
 white solid (0.63 g, 43%). 1H NMR (DMSO-d6) ) ppm 6.88 (d, 2H), 6.55 (d, 2H), 5.44 
(s, 1H), 4.85 (m, 1H), 4.36 ( m, 3H), 3.85 (d, 1H), 3.66-3.55 (m, 3H), 3.48 (d, 1H), 3.27 
(dd, 1H), 2.99 (dd, 1H), 2.14 (s, 3H). 
 
2.5.54 Synthesis of 2-amino-6-((2R,3S)-2,3,4-trihydroxybutyl)pteridin-4(3H)-
one (41) 
A mixture of 2,5,6-triaminopyrimidin-4-ol (210 mg, 1.5 mmol), p-tolyl-D-
isoglucosamine (198 mg, 0.73 mmol), sodium acetate (225 mg) and boric acid (60 mg) 
in water (5 ml) was heated in a stream of argon for 6 h on water bath. A grayish brown 
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solid separated out. The product was filtered and washed with acetone (20 mL) and 
ethanol till the filtrate was colorless. This was followed by ether wash. The buff colored 
solid was dissolved in 1N HCl (30 ml). The solution was treated with charcoal and 
filtered to remove the charcoal. The resulting filtrate was neutralized with ammonia and 
the neutralized solution was left in the cold room overnight. This resulted in yellow 
precipitate, (0.1 g, 51%). 1H NMR (DMSO-d6) ) ppm 8.54 (s, 0.5H), 8.28 (s, 0.5H), 6.90 
(bs, 2H), 4.66 (m, 2H), 4.38 (bs, 1H), 3.83, 3.76 (2bs, 1H), 3.45 (m, 1H), 3.39 (m, 2H), 
3.12 (m, 1H), 2.81 (m, 1H). 
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3. THIAMIN PYRIMIDINE SYNTHASE 
 
3.1 Introduction to thiamin pyrimidine synthase - ThiC 
Thiamin pyrophosphate is an essential cofactor in all forms of life.50 It plays a 
key role in amino acid and carbohydrate metabolism. Thiamin pyrophosphate 
biosynthesis has been extensively studied.51,52 There are unique biosynthetic pathways in 
bacteria and eukarkaryotes.53-56 The bacterial thiamin pyrimidine synthase, ThiC, a 
radical AdoMet enzyme, catalyzes a remarkable rearrangement reaction where it 
converts aminoimidazole ribonucleotide (AIR, 1) to the thiamin pyrimidine - 4-amino-5-
hydroxymethyl-2-methylpyrimidine phosphate (HMP-P, 2) and S-Adenosyl methionine 
(AdoMet, 3) to 5’-Deoxydenosine (5’dA, 5) as shown in Figure 3.1.1,26-28 
 
 
 
 
 
 
 
 
 
Figure 3.1: ThiC catalyzed conversion of AIR (1) to HMP-P (2) and AdoMet (3) 
to 5’dA (5) and methionine (6). 
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Previous studies have established the C, N and H labeling pattern on HMP and 
5’dA. It has been shown that ThiC is a novel radical SAM enzyme where one molecule 
of 5’-deoxyadenosyl radical is involved in two hydrogen atom abstractions (Figure 3.2). 
Figure 3.2 illustrates the C, N and H labeling pattern on HMP-P and 5’dA.1,26,27,57-59 
 
(A) 
 
 
 
(B) 
 
Figure 3.2: C, N and H labeling pattern on HMP-P and 5’dA in the ThiC-
catalyzed reaction and active site of At.ThiC. 
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Current mechanistic proposal for ThiC-catalyzed reaction is shown in Figure 3.3.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.3: Mechanistic proposal for ThiC-catalyzed reaction.  
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gives 13. Transfer of hydrogen atom from 5’dA regenerates 5’dA radical (4) and gives 
intermediate 14. The regenerated 5’dA radical abstracts a hydrogen atom from the 4’ 
position to give 15. Radical addition to heterocycle gives (16), followed by β bond 
scission gives ring expanded compound 17. β bond scission gives 18 and 19. 19 
undergoes dioldihydratase like reaction to generate 20 that undergoes radical addition to 
give 21. Radical rearrangement give 22. Addition of water and loss of formate gives 24. 
Loss of CO (8) followed by loss of electron gives final product HMP-P (2). 27 
 
3.2 Results and discussion 
3.2.1 Identification of the origin of the C5’ hydrogen of HMP-P 
Based on the mechanistic proposal there is a transfer of hydrogen atom from 
adenosyl radical onto intermediate 13 to give 14. If the early steps of the mechanism are 
correct, this hydrogen atom transferred from adenosyl radical should end up at C5’ of 
HMP-P (2).  
To test this, the two reactions shown in Figure 3.4 were carried out and the 
resulting HMP-P was dephosphorylated and analyzed by ESI MS. The first reaction was 
performed using purified ThiC with 5’-2H2-AIR and unlabeled AdoMet, the experiment 
previously carried out with cell free extract, and as expected gives monodeuterio-HMP 
(27) as indicated by the m/z = 141.1Da peak in the mass spectrum (Figure 3.4). The 
second ThiC reaction, using AdoMet enzymatically synthesized from universally 
deuteriated ATP and 5’-2H2-AIR, gave dideuterio-HMP (29) (m/z = 142.1Da). This 
experiment confirms that one of the C5’ hydrogens of HMP-P is derived from the 
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adenosyl radical and completes the identification of the origin of all of the atoms 
generated in the complex ThiC-catalyzed rearrangement reaction. 
 
 
 Figure 3.4: Incorporation of a deuterium atom from AdoMet. (A) m/z = 141.1 
corresponds to monodeutrio HMP (B) m/z = 142.1 corresponds to the dideuterio HMP-
P. 
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R-5’-2H-HMP and S-5’-2H-HMP60,61  and demonstrated that R- and S-monodeuterio 
HMP could be differentiated by NMR analysis of these esters (Figure 3.5).  
 
 
Figure 3.5: Stereochemical analysis of the deuterium atom incorporated from 
AdoMet. (A) ThiC reconstitution with 5’-2H2-AIR and SAM generates chiral centre on 
mono deuterated HMP as indicated by *. (B) The top three NMR traces are the reactions 
of standards for HMP with 1-(S)-camphanic chloride. The bottom trace represents the 
reaction of HMP purified by ThiC reconstitution with 5’-2H2-AIR and unlabeled 
AdoMet followed by phosphatase treatment. This shows that the hydrogen atom on 
mono deuterated HMP-OH from ThiC is on pro S face. 
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3.2.3 Summary of active-site mutant studies for ThiC 
The ThiC catalyzed transformation is amazingly complex. To understand the 
mechanistic details of this reaction, it would be of significant value to trap AIR derived 
intermediates in the ThiC catalyzed reaction. With this view, several ThiC active site1 
mutants were tested. Table 3.1 summarizes the results of this study. 
 
Table 3.1 ThiC - active site mutant studies. 
Active site 
mutant 
5’dA detection AIR derived product 
detection 
C.c. ThiC 
M248L 
5’-deoxyAdenosine is formed 
in levels comparable to wt. 
C.c. ThiC. 
5’ hydrogen atom from AIR is 
abstracted. But 4’ hydrogen 
atom from AIR is not 
abstracted. 
No AIR derived 
product was detected 
by LCMS or 32P 
assays. Analyzed the 
protein by trypsin 
digest to look for 
modification. But no 
modification detected 
C.c. ThiC 
C474S 
5’ and 4’ H atom abstracted 
from AIR. 
NMR experiments 
indicate product is 
unstable or more than 
one product formed. 
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Table 3.1 Continued. 
Active site 
mutant 
5’dA detection AIR derived product 
detection 
C.c. ThiC 
H417A 
5’ and 4’ H atom abstracted 
from AIR. 5’dA formed in 
low levels. 
HMP-P formed in 
very low .amounts. 
Detected by 32P  
assays. Also, detected 
by LCMS 
C.c. ThiC 
H481A 
5’-deoxyadenosine formed in 
low levels 
HMP-P formed in 
very low amounts 
C.c. ThiC 
S333A 
No 5’dA formation detected. 
Isolated protein did not bind  
[4Fe-4S] cluster. 
NA 
C.c. ThiC 
R377K 
5’-deoxyAdenosine is formed 
in very low levels. However, 
no deuterium atom 
incorporation from AIR was 
found 
No AIR derived 
product detected 
C.c. ThiC 
Y277F 
5’ and 4’ H atom abstracted 
from AIR 
HMP-P not detected. 
Possibly trace levels 
of AIR derived 
product observed.  
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Table 3.1 Continued. 
Active site 
mutant 
5’dA detection AIR derived product 
detection 
C.c. ThiC 
Y440F 
5’DeoxyAdenosine formed in 
very low levels. No other 
product detected 
No AIR derived 
product detected 
C.c. ThiC 
H417A-
H481A 
Very low levels of 5’-
deoxyadenosine detected 
Trace levels of HMP-
P detected 
A.t. ThiC 
N228S 
5’dA formed HMP-P formed. No 
intermediate detected 
A.t. ThiC 
T320A 
5’dA formed HMP-P formed. No 
intermediate detected 
A.t. ThiC 
D383N 
5’dA formed HMP-P formed. No 
intermediate detected 
A.t. ThiC 
M257L 
5’dA formed Possible intermediates 
detected at trace 
levels. 
 
A.t. ThiC 
C484S 
5’dA formed HMP-P formed. No 
intermediate detected. 
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Table 3.1 Continued. 
Active site 
mutant 
5’dA detection AIR derived product 
detection 
A.t. ThiC 
T320C 
5’dA formed HMP-P formed. No 
intermediate detected. 
A.t. ThiC 
M257C-
T320C-
E422C 
5’dA formed HMP-P not formed. 
No AIR derived 
product detected. 
A.t. ThiC 
M257C-
T320C-
E422C-
L259C 
5’dA formed HMP-P not formed. 
No AIR derived 
product detected. 
 
It can be seen from the Table 3.1 that in case of some of the mutants, AIR 
derived intermediates can be detected. However, trace levels of products were detected 
making it impossible for complete NMR characterization of the products. 
 
3.3 Conclusion 
We demonstrated that one of the C5’ hydrogens of HMP-P was derived from the 
adenosyl radical. This completed the identification of the origin of all of the atoms 
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generated in the complex ThiC-catalyzed rearrangement reaction. We have previously 
demonstrated that adenosyl radical abstracts the proS hydrogen from the C5 position of 
AIR. At some point during the reaction, 5’dA transfers the hydrogen atom on to AIR 
derived intermediate, which eventually forms HMP-P (mechanistic proposal shown in 
Figure 3.3). The HMP-P stereochemistry demonstrates that this hydrogen atom 
abstraction occurs from the si face of the radical resulting in overall retention of 
stereochemistry for the C5’ hydrogen atom replacement reaction. 
We performed several active-site mutant studies with a view to trap and 
characterize intermediates in the ThiC catalyzed reaction. In case of some of the 
mutants, AIR derived intermediates can be detected. However, trace levels of products 
are formed thus making it impossible for complete NMR characterization of these 
products. 
 
3.4 Experimental  
3.4.1 Over-expression of C.c. ThiC 
A full length clone of C.c. ThiC in pET28 vector was co-transformed with 
pDB1282, a plasmid encoding genes responsible for the Fe/S cluster biogenesis 
machinery, into E. coli B834(DE3). A 15 mL overnight culture of the resulting strain in 
LB was used to inoculate 1.8 L of sterilized M9 minimal medium, supplemented with 
100 mg/L ampicillin and 40 mg/L kanamycin, and was allowed to grow at 37 °C till the 
OD600 reached 0.2 – 0.25. At this point, ferrous ammonium sulfate, L-cysteine and L-
arabinose were added to final concentrations of 100 µM, 300 µM and 0.2% (w/v) 
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respectively and the growth was allowed to continue with slow shaking (100 rpm). Once 
the OD600 reached 0.65 – 0.7, the cultures were cooled with ice-water and IPTG was 
added to a final concentration of 10 µM. The protein overexpression was continued at 15 
°C at 50 rpm for 24 hours. The flasks were then incubated at 4 °C for 3 hours and the 
cells were then harvested and stored under liquid nitrogen till future use. 
 
3.4.2 Over-expression of A.t. ThiC 
Previous studies reported11 that overexpression of full-length AtThiC containing 
644 residues results in insoluble protein whereas overexpression of ΔN71-AtThiC with 
residues 1-71 removed results in soluble protein with high yield (1,2).  In the present 
study, ΔN71-AtThiC was cloned into a modified pET-28 plasmid that encodes the 
following hexahistidine-tagged protein product: 
NH2- MGSDKIHHHHHHSSGENLYFQGHMK72…K644-COOH”. 
This plasmid was transformed into E. coli BL21(DE3) cells.  Large-scale cultures 
were grown in baffled shake flasks containing 1.5 L of LB medium, 0.051 g 
chloramphenicol, and 0.06 g kanamycin.  The flasks were shaken at 180 rpm and 37 ºC 
until an optical density at 600 nm (OD600) of 0.5-0.55 was reached and then moved to a 4 
ºC cold room.  About 1.5 hours later, 200 mg ferrous ammonium sulfate, 200 mg L-
cysteine, and 36 mg isopropyl β-D-1-thiogalactopyranoside (IPTG) were added per flask 
and the flasks were shaken at 90 rpm and 15 ºC for about 20 hours.  The flasks were then 
moved to the cold room for about 2 hours before being pelleted by centrifugation, flash 
frozen, and stored in liquid N2. 
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3.4.3 Purification of A.t. ThiC and C.c. ThiC 
For enzyme purification, the cell pellets were thawed at room temperature in an 
anaerobic chamber and suspended in lysis buffer (100 mM Tris-HCl, pH 7.5) in the 
presence of 2mM DTT, lysozyme (0.2 mg/ml) and benzonase (100 units).  This mixture 
was then cooled in an ice-bath for 2 hrs. The suspension of cells was then sonicated and 
centrifuged to give the cell-free extract. The enzyme was then purified using standard 
Ni-NTA chromatography. The column was first incubated with the lysis buffer. The cell-
free extract was then passed over the column, which was then washed with 5-6 column 
volumes of wash buffer (100 mM Tris-HCl, 300 mM NaCl, 20 mM imidazole, 2mM 
DTT, pH 7.5). The protein was then eluted using 100 mM Tris-HCl, 300 mM NaCl, 250 
mM imidazole, 2 mM DTT, pH 7.5. The purified enzyme was buffer exchanged into 100 
mM potassium phosphate, 30% glycerol, 2 mM DTT, pH 7.5 using a 10DG column and 
the purified enzyme was stored in liquid nitrogen. 
 
3.4.4 Over-expression and purification of S-adenosylmethionine synthetase 
SAM synthetase-GFP over-expression plasmid was a gift from Dr. David P. 
Barondeau’s lab. This plasmid was transformed in E. coli BL21(DE3) cells. 5ml per litre 
of the starter culture was added to 6 liters of Luria Broth media. The cells were allowed 
to grow till OD600 reached 0.6. Then the cells were cooled to 40 C for one hour. Then 
0.5mM of IPTG was added to the media. The culture was shaken at 150 C for 12 hrs.  
The cells were then harvested by centrifugation. The cells were suspended in 
lysis buffer (100mM potassium phosphate, 300mM NaCl, 10mM imidazole). They were 
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sonicated and centrifuged to remove the cell debris. The protein was purified by Ni-NTA 
column. After loading the protein on Ni-NTA column, the column was washed with 
wash buffer (100mM potassium phosphate buffer, 300mM NaCl, 50mM imidazole, pH 
7.5, 5 column volumes). The protein was eluted off the column using 250mM imidazole. 
The protein was desalted in 100mM potassium phosphate buffer, 30% glycerol, pH 7.5, 
using 10DG desalting columns. The protein was stored in -800C. 
 
3.4.5 ThiC-SAM synthetase coupled assays 
50µL of SAM synthetase (200µM) was incubated in an anaerobic chamber with 
5mM of ATP and 5mM of methionine in a buffer containing 100mM Tris-HCl pH 8, 
20mM MgCl2, 200mM KCl. The assays were allowed to stand in the anaerobic chamber 
for 3 hrs. ThiC reconstitution assays were set up in an anaerobic chamber. 200µL of 
280µM ThiC was incubated with excess of dithionite for 10 mins. Then 6.7µL of 30mM 
AIR was added to the ThiC reconstitution mixture. This was followed by addition of 
SAM from the SAM synthetase mixture. 
 
3.4.6 ThiC assay conditions 
ThiC reconstitution assays were set up in an anaerobic chamber. 200µL of 
280µM ThiC was incubated with excess of dithionite for 10 mins. Then 6.7µL of 30mM 
AIR was added to the ThiC reconstitution mixture. This was followed by addition of 
7µL of 50mM SAM. 
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3.4.7 Alkaline phosphate treatment of HMP-P purified after ThiC
reconstitution
Alkaline phosphatase 2µL (1000 units) was added per ml of HMPP purified after 
adjusting the pH of the solvent containing HMPP to 7.5. Then 5µl of MgCl2 (1M) was 
added to this mixture. The mixture was incubated at 370C for 6 hours. 
3.4.8 Sample preparation for mass spectrometry experiments
The buffer exchanged HMP was concentrated using speed vacuum. When 500 µl 
of solvent was remaining, 10 ml of water was added to it. Then this sample was again 
subjected to speed vaccum to concentrate it. This process was done at least three times to 
ensure maximum removal of ammonium formate. This resulted in optimum signal for 
mass spectrometry experiments. 
3.4.9 Enzymatic sample - derivatization for stereochemistry experiment
Around 60 ml of HMP was buffer exchanged. The entire HMP buffer exchanged 
was concentrated to 5 ml using speed vacuum. It was diluted to 12ml using water. Again 
it was concentrated to 500µl. Then 10ml of water was added to this mixture and it was 
again concentrated to 500µl. This was done three times. The 500µl remaining was 
stripped to dryness using speed vacuum. 
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3.4.10 Reference standard sample – derivatization for stereochemistry
experiment 
Dry HMP was dissolved in 200µl of dry dichloromethane. 4 μL of dry pyridine 
was added to this mixture under argon. The mixture was allowed to stir for 10 min under 
argon. 1.5mg of 1-(S)-camphanic chloride was then added to this mixture and the 
reaction was allowed to stir overnight under argon. Then 3ml of ethyl ether and 200µl of 
water was added to this mixture. Separate the organic phase from the aqueous phase. 
Anhydrous sodium sulfate is then added to the organic phase. This is then passed 
through a cotton plug for filteration.  The organic solvent was then removed in vacuo 
and the product was analyzed by NMR (CDCl3). In all NMR experiments the chemical 
shifts were referenced to chloroform chemical shift. 
3.4.11 HPLC purification of HMP-P from ThiC reconstitution mixture
The ThiC reconstitution assays were purified by reverse phase C18 column using 
HPLC. (Supelcosil, SPLC-18, 5µm,25cmx10mm). Following conditions were used for 
HPLC purification. Solvent A: H2O, solvent B: 100mM potassium phosphate pH 6.6, 
solvent C: methanol. 0min – 100%B, 7min – 10%A, 90%B, 12min – 25%A, 60%B, 
15%C, 17min – 25%A, 10%B, 65%C, 19min – 100%B, 29min 100%B. For 
stereochemistry analysis several ThiC assays were purified to collect HMPP and for 
each mass spectrometry experiments three ThiC assays were purified.
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3.4.12 HPLC buffer exchange of Alkaline phosphatase mixture 
The alkaline phosphatase mixture was again purified by HPLC using C18 
column (Supelcosil, LC-18DB, 5µm, 25cmx4.6mm) to collect HMP. The solvents that 
were used for HPLC were; Solvent A – H2O, Solvent B – 5mM ammonium formate, 
Solvent C – methanol. Following was the gradient used: 0 min – 100%B, 1min- 100%B, 
6 min – 20%A, 20%B, 60%C, 11 min – 100%B, 17 min – 100%B.
3.4.13 Synthetic scheme for camphanic esters of HMP (31, 32, 33)60,61 
The synthetic scheme for (31) and (33) is shown in Figure 3.6. 
Figure 3.6: Synthetic scheme for camphanic esters of HMP (31, 32, 33). 
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3.4.14 Synthesis of 4-amino-5-(hydroxymethyl)-2-methylpyrimidine (HMP,
35)
10ml of 5% HCl was added to 136 mg of Grewe diamine at 00 to 50 C. The 
mixture was allowed to stir for 10 mins at this temperature. It was then heated to 900 C. 
Then 10 ml of 10mM solution of NaNO2 was then added drop wise at this temperature. 
After the completion of addition the reaction mixture was immediately cooled and then 
titrated to pH 8.5 using 40% NaOH solution. 
3.4.15 Synthesis of 4-amino-5-cyano-2-methylpyrimidine (38)
0.95 g of acetimidine hydrochloride (36) was dissolved in 200ml of anhydrous 
ethanol. 0.3g of sodium was then dissolved in anhydrous ethanol and this solution was 
added to the acetimidine solution. The mixture was allowed to stirred till no further solid 
precipitation was observed. It was then filtered. 1.22g of ethoxymethylene malonontrile 
(37) was dissolved in 10ml of anhydrous ethanol and was added to the above filtrate. 
The mixture was allowed to stir for 3.5hrs. The product of this reaction is then filtered 
and analyzed by NMR. The yield of this reaction is about 64%. 
3.4.16 Synthesis of 4-amino-5-carbaldehyde-2-methylpyrimidine (39)
100mg of 4-amino-5-cyano-2-methylpyrimidine were added to 10ml of dry THF. 
This mixture was cooled down to -100 C. This mixture was allowed to stir at -100 C for 
30 mins. Then 29 mg of lithium aluminum deuteride was added in parts such that the 
temperature does not increase beyond -50 C. The reaction mixture was allowed to stir for 
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2 hrs. Then 5ml of methanol was added to this mixture. Flash column was used to purify 
the product. 5% methanol and ethyl acetate were used for silica gel flash 
chromatography. The solvent was evaporated in vacuo and a pure white solid was 
obtained. 
3.4.17 Synthesis of 4-amino-5-R-D-(hydroxymethyl)-2-methylpyrimidine (41)
150 mg of aldehyde was mixed with 12ml of dry THF. 4.2 ml of S-alpine borane 
was added to this mixture under argon. The reaction mixture was allowed to stir for 3 
hrs. After 3 hours, 4 ml of methanol and 4ml of water was added to this mixture. The R 
isomer was purified using silica gel flash column. 35% methanol in ethyl acetate was 
used for silica gel chromatography. 
3.4.18 Synthesis of 4-amino-5-S-D-(hydroxymethyl)-2-methylpyrimidine (40)
Exactly same procedure was followed as above. Except in this case, R-alpine 
borane was used instead of S-alpine borane for the reduction of (39) to (40) as shown in 
the Figure 3.6.
3.4.19 Preparation of camphanic ester of HMP (31, 32, 33) 
10mg of dry HMP was dissolved in 1ml of dry dichloromethane. 16 μL of dry 
pyridine was added to this mixture under argon. The mixture was allowed to stir for 10 
min under argon. 15mg of 1-(S)-camphanic chloride was then added to this mixture and 
the reaction was allowed to stir for 2hrs. Then 3ml of ethyl ether and 1ml of water was 
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added to this mixture. Separate the organic phase from the aqueous phase. Anhydrous 
sodium sulfate is then added to the organic phase. This is then passed through a cotton
plug for filtration.  The organic solvent was then removed in vacuo and the product was 
analyzed by NMR (CDCl3). The two diastereomeric hydrogen atoms (Figure 3.5B) were 
confirmed by dqf COSY and HSQC experiments. The overlapping doublet of doublet in 
Figure 3.5B for compound 31 couples to each other (geminal A-B system). HSQC  
demonstrates that these two hydrogen atoms are on the same carbon atom. 
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4. ANAEROBIC VITAMIN B12 BIOSYNTHESIS –
HYDROXYBENZIMIDAZOLE SYNTHASE
4.1 Background and introduction 
ThiC, thiamin pyrimidine synthase catalyzes a remarkable reaction, where 
aminoimidazole ribotide (AIR, 1) is converted to 4-amino-2-methyl-5-hydroxymethyl 
pyrimidine (HMP-P, 3), carbon monoxide (CO, 6), and formate (5) (Figure 4.1).1,27 
Several studies labeling and mechanistic studies have been performed on the thiamin 
pyrimidine synthase, ThiC.1,26,27,58 It has been shown that ThiC belongs to the radical 
SAM family of enzymes and generates 5’-deoxyadenosyl radical (5’-dA radical, 2), 
which sequentially abstracts hydrogen atom from 5’ and 4’ position of AIR. 27 
 
Figure 4.1: ThiC-catalyzed reaction - C, N and H labeling pattern on HMP-P and 
5’dA. 
We extensively tried to investigate the mechanistic details of ThiC catalyzed 
reaction. We also observe possible AIR derived intermediates in this complex reaction. 
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AdoMet enzymes, does a fraction of a turn-over making it very challenging to trap trace 
level products. 
We decided to look for ThiC paralogs from different organisms that work better 
or catalyze different, more tractable chemistry. Bioinformatics search for thiamin 
biosynthetic genes (in particular ThiC) in the SEED database 
(http://theseed.uchicago.edu/FIG/index.cgi) revealed that there are several 
microorganisms that have more than one copies of ThiC. From the set of organisms that 
have multiple copies of ThiC, we observed that there is a subset of organisms where one 
of these copies of ThiC (which we named as ThiC-1) was clustered with vitamin B12 
biosynthetic genes. Also, many of these organisms are listed as anaerobic 
microorganisms. Anaerobic biosynthesis of vitamin B12 has been extensively studied62-
72. However, the gene product(s) responsible for the biosynthesis of the “lower ligand” 
of vitamin B12 – dimethylbenimidazole is (are) unknown.  In the aerobic pathway, BluB 
– the flavin destructase catalyzes the oxidative conversion of flavin mononucleotide 
(FMN, 7) to dimethylbenzimidazole (DMB, 8) as shown in the Figure 4.2.73,74  
 
 
 
 
 
Figure 4.2: BluB catalyzed DMB biosynthesis.  
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Based on these observations, we decided to test the in vitro enzymatic activity of 
ThiC-1. 
 
4.2 Results and discussion 
 4.2.1 Reconstitution of ThiC-1 as hydroxybenzimidazole synthase (HBI 
synthase) 
We decided to synthesize and clone the nucleotide sequence of Desulfuromonas 
acetoxidans ThiC paralog (ThiC-1) clustered with vitamin B12 biosynthetic genes. We 
heterologously co-overexpressed in E. coli with plasmid containing genes from suf 
operon for [4Fe-4S] cluster biosynthesis. ThiC-1 as isolated binds to a [4Fe-4S] cluster 
as shown in Figure 4.3A. The enzymatic assays with HBI synthase in presence of AIR, 
SAM and dithionite results in the formation of 5’-dA (4) as shown by the signal at 
31min in the HPLC chromatogram  (Figure 4.3B). This was confirmed by LCMS. Also, 
a unique signal was observed at 22.7 min only in the full reaction where all the 
components were present and not observed in any of the controls where either of ThiC-1, 
AIR, SAM or dithionite was absent (Figure 4.3B). This signal had an [M+H]+ of 135.05 
Da (Figure 4.3D) which is identical to that of 5-HB.  
To confirm the formation of 5-hydroxybenzimidazole (5-HB) we co-injected a 
reference standard for 5-HB with the ThiC-1 full reaction. The enzymatic product and 
the reference standard co-elute as shown in (Figure 4.3). 
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Figure 4.3: Reconstitution of ThiC-1 as HBI synthase. (A) UV-Vis spectrum of 
HBI synthase as isolated. (B) HPLC (254nm) chromatograms for HBI synthase reactions 
with controls. A unique signal observed in the full reaction at 22.7min retention time. 
(C) Red chromatogram – reference standard for 5-HB. Blue chromatogram - enzymatic 
reaction containing all the components - HBI synthase, AIR, SAM and dithionite (full 
reaction). Green Co-injection of the reference standard corresponding to 5-HB and the 
full reaction. This indicates that the reference standard and the enzymatic product co-
elute. (D) MS indicates an [M+H]+=135.05 Da for the enzymatic product. This is 
consistent with the [M+H]+ for 5-HB. 
 
Similar to ThiC, ThiC-1 uses AIR (1) and AdoMet as a substrate. SAM is 
converted to 5’-deoxyadenosine (5’-dA, 6). However, unlike the ThiC reaction, ThiC* 
catalyzed reaction converts AIR to 5-hydroxybenimidazole (5-HB, 10). 5-HB (10) has 
been previously proposed to be an intermediate in the anaerobic dimethylbenzimiadole 
/vitamin B12 biosynthesis.69 Our study identifies the gene product responsible for the 
formation of this key ligand of vitamin B12. We renamed ThiC-1 as 
hydroxybenzimidazole synthase (HBI synthase). 
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Figure 4.4: Reconstitution of ThiC-1 as a radical SAM enzyme as 
hydroxybenzimidazole synthase (HBI synthase). 
 
4.2.2 HBI synthase reactions with 13C-labeled AIR isotopomers  
HBI synthase reactions with 13C-labled AIR were analyzed by LCMS. Figure 4.5 
and Table 4.1 summarizes these results. The reactions with 1’,2’,3’,4’,5’-13C5-AIR 
resulted in the [M+H]+ = 139.06 Da for 5-HB indicating that only 4 of the 5 13C labeled 
carbons were incorporated in 5-HB. The reactions with 3’-13C-AIR and 2’-13C-AIR 
showed an  [M+H]+ = 136.05 Da thereby indicating a single 13C incorporation in 5-HB 
formed in both these reactions. The reaction with 1’-13C-AIR resulted in an  [M+H]+ = 
135.05 Da indicating that 1’-C of AIR is not incorporated in 5-HB. The mass spectrum 
of each of these results is shown in Figure 4.5. 
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(A)  
 
 (B)  
 
 (C)  
 
Figure 4.5: HBI synthase reactions with 13C-AIR. (A) MS for 5-HB - HBI 
synthase reaction with 1’,2’,3’,4’,5’-13C5-AIR. (B) MS for 5-HB - HBI synthase reaction 
with 3’-13C –AIR. (C) MS for 5-HB - HBI synthase reaction with 2’-13C –AIR (D) MS 
for 5-HB - HBI synthase reaction with 1’-13C -AIR 
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 (D)  
 
Figure 4.5 Continued. 
 
Table 4.1 summarizes the LCMS results. 
 
Table 4.1: Summary of HBI synthase reactions with 13C-AIR. 
Substrate 5-HB [M+H]+ Da 
1’,2’,3’,4’,5’-13C5-AIR  139.0 
3’-13C-AIR 136.0 
2’-13C-AIR 136.0 
1’-13C-AIR 135.0 
15N-AIR 135.0/136.0 
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4.2.3 HBI synthase – fate of 1’-C of AIR 
Having figured out that 1’-C of AIR is not incorporated in to 5-HB, we wanted to 
determine the fate of 1’-C of AIR. HBI synthase reactions were performed with 
1’,2’,3’,4’,5’-13C5-AIR. NMR analysis of the small molecule pool of these HBI synthase 
reactions showed a unique signal that was observed in 13C-NMR (Figure 4.6) and DEPT 
90 NMR (Figure 4.6D - 4.6F ). The ppm shift and the observation of the DEPT 90 signal 
suggested the possible product could be formate (5). In order to confirm this, we spiked 
in a reference standard of formate (5) (final concentration 50mM) in the full reaction. 
This matched with the signal at 172 ppm in 13C-NMR (Figure 4.6D) and DEPT 90 NMR 
(Figure 4.6A). This suggests that the 1’-C of AIR is lost as formate (5).  
 
 
Figure 4.6: HBI synthase – fate of 1’-C of AIR (A-C) DEPT 90 NMR of small 
molecule pool of HBI synthase reactions with 1’,2’,3’,4’,5’-13C5-AIR. (A) HBI synthase 
reaction with 1’,2’,3’,4’,5’-13C5-AIR in presence of SAM, reductant. The reactions were 
spiked in with formate (10mM) after 2hrs. (B) HBI synthase reaction with 1’,2’,3’,4’,5’-
13C5-AIR in presence of SAM, reductant (C) No Dithionite – control. HBI synthase 
reaction with 1’,2’,3’,4’,5’-13C5-AIR in presence of SAM and absence of dithionite. (D-
F) 13C NMR of small molecule pool of HBI synthase reactions with 1’,2’,3’,4’,5’-13C5-
AIR. (D) Green – Full reaction + 50mM formate. (E) Blue – Full reaction. (F) Red – No 
Dithionite control. 
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4.2.4 HBI synthase reactions with 2H-labeled AIR isotopomers  
HBI synthase reactions with 13C-labled AIR were analyzed by LCMS. Figure 4.7 
- Table 4.2 summarizes the results. The reactions of HBI synthase with 5’,5’-2H2-AIR, 
followed by LCMS analysis suggested that the one of the deuterium atoms from 5’,5’-
2H2-AIR gets incorporated in to 5’-deoxyadenosine ([M+H]+=253.1 Da) where as the 
other deuterium atom gets incorporated in 5-HB ([M+H]+=136.05 Da). We then wanted 
to identify the preference of 5’-deoxyadenosyl radical to abstract pro R or pro S 
hydrogen atom from AIR. HBI synthase reactions with 5’-R-2H-AIR revealed an 
[M+H]+=252.1 Da for 5’-dA and [M+H]+=136.05 Da for 5-HB indicating that the 
deuterium atom from 5’-R-2H-AIR is not abstracted by 5’-deoxyadenosyl radical and is 
incorporated on the final product 5-HB. HBI synthase reactions with 5’-S-2H-AIR 
revealed an [M+H]+=252.1/253.1 Da for 5’-dA and [M+H]+=135.05 Da/136.05 Da for 5-
HB indicating that there is a preference for deuterium atom abstraction by 5’-dA radical 
from 5’ pro S of AIR. Reactions with 4-2H-AIR revealed that the deuterium atom from 
AIR is retained on the final product 5-HB and is not abstracted by 5’-dexoxyadenosyl 
radical. The mass spectrum of each of these results is shown in Figure 4.7. 
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(A) MS for 5’dA 
 
 (B) MS for 5-HB 
 
MS for 5’-dA 
 
Figure 4.7: HBI Synthase reactions with 2H-AIR. (A) HBI synthase reaction with 
AIR - MS for 5’-dA. (B) HBI synthase reaction with 5’,5’-2H2-AIR - LCMS data for 5-
HB and 5’-dA. (C) HBI synthase reaction with 5’-R-2H-AIR - LCMS data for 5-HB and 
5’-dA. (D) HBI synthase reaction with 5’-S-2H-AIR - LCMS data for 5-HB and 5’-dA. 
(E) HBI synthase reaction with 4-2H-AIR - LCMS data for 5-HB and 5’-dA. 
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 (C) MS for 5-HB 
 
MS for 5’-dA 
 
 (D) MS for 5-HB 
 
 
MS for 5’-dA 
 
Figure 4.7 Continued. 
 
136.1
137.1
+MS, 17.9-18.1min #(1059-1075)
0.0
0.5
1.0
1.5
4x10
Intens.
134 135 136 137 138 139 m/z
136.05'
137.05'
252.1
253.1
+MS, 25.3-25.3min #(1501-1503)
0
1
2
3
5x10
Intens.
249 250 251 252 253 254 255 256 m/z
252.1%
253.1%
136.1
137.1
138.1
135.1
+MS, 17.0-17.2min #(1007-1023)
0
1
2
3
4
4x10
Intens.
134.0 134.5 135.0 135.5 136.0 136.5 137.0 137.5 138.0 138.5 m/z
1 5.05& 13 .05&
137.05&
252.1
253.1
254.1
255.1
+MS, 25.3-25.3min #(1500-1502)
0.0
0.5
1.0
1.5
2.0
5x10
Intens.
250 252 254 256 258 260 262 m/z
254.1&
253.1&
252.1&
 	   96 
(E)  
MS for 5-HB 
 
MS for 5’-dA 
 
Figure 4.7 Continued. 
 
Table 4.2 summarizes the LCMS studies of HBI synthase reaction with 2H-AIR 
isotopomers. This table complies and highlights the deuterium-labeling pattern on 5-HB 
and 5’dA. 
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 Table 4.2: HBI synthase reaction with 2H-AIR isotopomers. 
Substrate 5-HB [M+H]+ Da 5’dA [M+H]+ Da 
Unlabeled AIR 135.0 252.0  
5’,5’-2H2-AIR 136.0 253.0 
5’-R-2H-AIR 136.0 252.0 
5’-S-2H-AIR 135.0/136.0 252.0/253.0 
4’-2H-AIR 135.0 252.0 
 
 This study shows that unlike ThiC where a single 5’dA radical sequentially 
abstracts 4’ and 5’ hydrogen atoms from AIR, in case of HBI synthase the 5’dA radical 
abstracts only the C5’ hydrogen. There is a preference for the abstraction of pro S C5’ 
hydrogen as compared to pro R C5’. 
 
4.2.5 HBI synthase reactions with 15N-AIR  
AIR where the amino group was 15N labeled was synthesized (15N-AIR). HBI 
synthase reactions with 15N-AIR followed by LCMS analysis revealed a mixture of 
135.05 Da and 136.05 Da signals for 5-HB, there by indicating a mixture of 14N and 15N 
incorporated product in the final 5-HB (Figure 4.8). 
 
 
 	   98 
MS for 5-HB 
 
Figure 4.8: HBI synthase reaction with 15N-AIR - LCMS data for 5-HB. 
 
4.2.6 Characterization of labeling pattern on 5-HB  
5-HB from HBI synthase reactions with AIR, 5’,5’-2H2-AIR, 4-2H2-AIR and 2’-
13C-AIR was isolated. 1H-NMR was used to identify the location of label incorporation 
in 5-HB (Figure 4.9B-4.9F). 
It can be seen that the 1H NMR for the 5-HB isolated from the HBI synthase 
assays with unlabeled AIR (Figure 4.9C) matches with the standard 5-HB (Figure 4.9B).  
For the 5-HB isolated from the HBI synthase assays with 2’-13C-AIR, the doublet at 7.12 
ppm splits into two doublets due to 13C coupling to 1H. This indicates that the carbon at 
4 position of 5-HB generated has 13C label. For the 5-HB isolated from the HBI synthase 
assays with 4’-2H-AIR, the doublet of doublet at 6.9 ppm almost vanishes, indicating 2H 
incorporation at position 6 of the 5-HB isolated. For the 5-HB isolated from the HBI 
synthase assays with 5’,5’-2H2-AIR, the doublet 7.6 ppm vanishes, indicating 2H 
incorporation at position 7 of the 5-HB isolated. The summary of the labeling pattern 
from these studies is demonstrated in Figure 4.9. 
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Figure 4.9: Characterization of the labeling pattern on 5-HB. (A) Summary of 
labeling pattern on 5-HB (B) 1H NMR for 5-HB reference standard. (C)-(F): 1H NMR of 
5-HB purified from enzymatic reactions. Following were the substrates for each of these 
cases. (C) unlabeled AIR (D) 2’-13C-AIR (E) 4’-2H-AIR (F) 5’,5’-2H2-AIR. 
 
4.2.7 Discussion  
The aerobic and the anaerobic biosynthetic pathways for the corrinoid core in 
vitamin B12 are extensively studied.62 The lower ligand of vitamin B12 5,6-
dimethylbenzimidazole (DMB, 8) in the aerobic pathway involves a fascinating reaction 
catalyzed by BluB where FMN is converted to DMB in presence of oxygen (Figure 4.2). 
It was suggested that the aerobic and the anaerobic pathways are different for the DMB 
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biosynthesis.63,64 In case of the anaerobic pathway, previous feeding studies indicated 
that 5-HB and 5-hydroxy-6-methylbenzimidazole are the precursors to anaerobic DMB 
biosynthesis69. Precursors to these benzimidazoles were identified as glycine and D-
erythrose.63,65-67 Also, the gene(s) responsible for the biosynthesis of these precursors 
were unknown prior to our study.  
We reconstituted HBI synthase as a radical SAM enzyme that catalyzes the 
conversion of AIR (1) to 5-HB (10). Our studies suggested that AIR was a direct 
precursor to 5-HB. This is consistent with the previous studies as D-erythrose is the 
precursor to ribose-5-phosphate. Also, glycine is a substrate of the 
phosphoribosylamine-glycine ligase, an enzyme on the AIR biosynthetic pathway 
(purine metabolism).  
Several site-specifically isotopically labeled AIR were used to study the labeling 
pattern on 5-HB and 5’-dA.  Table 4.1, Table 4.2 and Figure 4.9A summarize the 
labeling data for 5-HB (10). 1’-C of AIR does not get incorporated in 5-HB (10). It is 
converted to formate (5).  
 
4.2.8 ThiC-HBI synthase homology model (Steve Ealick Lab, Cornell 
University) 
 We wanted to understand the structural details of HBI synthase. HBI synthase is 
homologous to thiamine pyrimidine synthase, ThiC. HBI synthase chemistry is similar to 
ThiC chemistry in terms of the generation of 5’-dA radical and abstraction of the pro S 
hydrogen atom by 5’-dA radical from C5’ of AIR. However, two significantly different 
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molecules, 5-HB (10) and thiamin pyrimidine (3) are formed as final products in the HBI 
synthase and ThiC respectively.  
We wanted to compare the active site of ThiC with HBI synthase to understand 
the differences in the reactivity. We have a high-resolution crystal structure of ThiC. A 
sequence alignment (Figure 4.10) and comparison of HBI synthase to ThiC demonstrates 
that most of the active site residues are conserved in HBI synthase. We made a 
homology model of HBI synthase based on ThiC structure (Figure 4.10A). Interestingly, 
the active site architecture remains very similar to ThiC. Key features that are different 
in HBI synthase are – serine in HBI synthase for an asparagine in ThiC between the AIR 
and SAM binding sites; alanine (HBI synthase) for threonine (ThiC) in the AIR ribose 
binding site, and a asparagine (HBI synthase) for aspartate (ThiC) in the imidazole 
binding site. This is an intriguing observation. We plan to study the mutant of HBI 
synthase with an intention to trap out reaction intermediates. We also plan to pursue 
structural studies on HBI synthase bound to 5-HB.  
It is quite remarkable that based on the homology model (Figure 4.10), the active 
site architecture of HBI synthase remains very similar to ThiC considering that two 
significantly different molecules, 5-HB (10) and thiamin pyrimidine (3) are formed as 
final products in the HBI synthase and ThiC respectively. 
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(C) 
 
 
 
 
Figure 4.10: HBI synthase homology model based on ThiC structure. (A) 
Proposed active site of HBI synthase (ThiC-1 - Desulfuromonas acetoxidans) homology 
model to thiamine pyrimidine synthase (B) Arabidopsis thaliana ThiC - Thiamin 
pyrimidine synthase active site. The active site residues that differ in HBI synthase as 
compared to ThiC are labeled in this figure. (C) Sequence alignment of A.t. ThiC, D.a. 
ThiC and D.a. ThiC-1 
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4.2.9 Mechanistic proposal for HBI synthase catalyzed reaction 
A mechanistic proposal consistent with our studies is shown in Figure 4.11. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.11: Mechanistic proposal for the HBI synthase catalyzed reaction.  
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cleavage of the C-N bond, followed by the C-C bond formation to connect the ribosyl 
part to the imidazole, gives intermediate (15, resonance form 17). Nucleophilic attack at 
C5’ connects (16) and (17) by a C-C bond to give (18). Loss of phosphate gives (19). 
Deprotonation, transfer of electron back to the [Fe-4S] cluster, tautomerization and 
addition of water gives (22). Ring closure and loss of formate gives (26). Ring closure 
followed by tautomerization and loss of water gives (29). Tautomerization and loss of 
water gives the final compound (5-HB, 10). The hypothetic intermediate (23) can be 
used to understand the scrambling of 15N in 5-HB in the HBI synthase reactions with 
15N-AIR.  
 
4.3 Conclusion 
We identified and reconstituted hydroxybenzimidazole synthase involved in 
vitamin B12 biosynthesis has solved an old and important puzzle in the anaerobic vitamin 
B12 biosynthesis. Our studies suggested that AIR was a direct precursor to 5-HB. This is 
consistent with the previous studies as D-erythrose is the precursor to ribose-5-
phosphate. Also, glycine is a substrate of the phosphoribosylamine-glycine ligase, an 
enzyme on the AIR biosynthetic pathway (purine metabolism).  
Several site-specifically isotopically labeled AIR were used to study the labeling 
pattern on 5-HB and 5’-dA. Table 4.1, Table 4.2 and Figure 4.9A summarize the 
labeling data for 5-HB (10). 1’-C of AIR does not get incorporated in 5-HB (10). It is 
converted to formate (5). We advance a mechanistic proposal consistent with our 
studies. 
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We are currently investigating the mechanistic details of this reaction using 
mechanistic probe molecules and X-ray crystallography 
 
4.4 Experimental 
4.4.1 Over-expression and purification of HBI synthase 
The nucleotide sequence of Desulformonas acetoxins ThiC homolog (HBI 
synthase) clustered with vitamin B12 biosynthetic genes was synthesized and cloned in 
THT vector (pET 28 vector that has a TEV protease cleavage site for removing the 
Histag). HBI synthase was co-expressed in the presence of a plasmid encoding the suf 
operon for in vivo [4Fe-4S] reconstitution in E. coli BL21 (DE3). An overnight 15 ml 
culture was grown in LB media in the presence of kanamycin (40mg/L) and 
chloramphenicol (25mg/L).  This was then added to a minimal media (containing M9 
minimal salts 1X, 27ml of 50% glucose, 7ml of 1M MgSO4, 200µl of 1M CaCl2, 
40mg/L kanamycin and 25mg/L chloramphenicol. The cultures were incubated at 370C 
with shaking (180 rpm) until the OD600 reached 0.6 to 0.65. The cultures were then 
incubated at 40C without shaking for 3 hrs. Then 50 mg of ferrous ammonium sulfate 
and 50 mg of cysteine were added. This was followed by induction of the culture with 70 
µM IPTG. The culture was then incubated at 150C with shaking (50 rpm) for 18 - 20hrs. 
The cultures were then incubated at 40C for 3 hrs without shaking. The cells were then 
harvested and stored in liquid nitrogen overnight before enzyme purification. For 
enzyme purification, the cell pellets were thawed at room temperature in an anaerobic 
chamber and suspended in lysis buffer (100 mM Tris-HCl, pH 7.5) in the presence of 
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2mM DTT, lysozyme (0.2 mg/ml) and benzonase (100 units).  This mixture was then 
cooled in an ice-bath for 2 hrs. The suspension of cells was then sonicated and 
centrifuged to give the cell-free extract. The enzyme was then purified using standard 
Ni-NTA chromatography. The column was first incubated with the lysis buffer. The cell-
free extract was then passed over the column, which was then washed with 8-9 column 
volumes of wash buffer (100 mM Tris-HCl, 300 mM NaCl, 20 mM imidazole, 2mM 
DTT, pH 7.5). The enzyme was then eluted using 100 mM Tris-HCl, 300 mM NaCl, 250 
mM imidazole, 2 mM DTT, pH 7.5. The purified enzyme was buffer exchanged into 100 
mM potassium phosphate, 30% glycerol, 2 mM DTT, pH 7.5 using an Econo-Pac 10DG 
desalting columns (commercially available from Bio-RAD) and the purified enzyme was 
stored in liquid nitrogen. The protein as isolated binds to a [4Fe-4S] cluster as indicated 
by the UV-Vis spectrum shown in Figure 4.3A. 
 
4.4.2 HBI synthase assays for LCMS and HPLC purification of 5-HB 
HBI synthase (120µM) was incubated with dithionite (10mM), AIR (5mM), 
SAM (7mM) at room temperature for 60min. Controls were set up where either of AIR, 
SAM, dithionite or HBI synthase is absent. The protein was filtered out using 10kDa cut 
off filters and the small molecule pool was analyzed by HPLC and LCMS. These assays 
were done with unlabeled AIR, 5’,5’-2H2-AIR, 4-2H2-AIR, 1’,2’,3’,4’,5’-13C5-AIR, 5’-R-
2H-AIR, 5’-S-2H-AIR, 1’-13C-AIR, 2’-13C-AIR, 3’-13C-AIR.  
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Same assay conditions were used for the purification of 5-HB for NMR 
characterization. These assays were done with unlabeled AIR, 5’,5’-2H2-AIR, 4-2H2-
AIR, 2’-13C-AIR. 
 
4.4.3 Enzymatic assays for NMR analysis to determine the fate of 1’-C of 
AIR  
HBI synthase (800µM) was incubated with dithionite (50mM), 1’,2’,3’,4’,5’-
13C5-AIR (20mM), SAM (30mM) at room temperature for 60min. Controls were set up 
where either of AIR, SAM, dithionite or HBI synthase are absent. The protein was 
filtered out using 10kDa cut off filters. The small molecule pool was analyzed by 13C 
and DEPT 90 NMR experiments. 
 
4.4.4 HPLC conditions for co-elution experiment and purification of 5-HB  
HPLC -1260 series Agilent. LC-18 column -  ((Supelcosil LC-18-T column 
(15cm x 3mm, 3µm)). Following gradient was used: A: water, B: 5mM ammonium 
formate, C: methanol. Following gradient was used - 0 min: 100%B; 7 min: 100%B; 25 
min: 7%A, 70%B, 23%C; 27 min: 25%A, 75%C; 29 min - 25%A, 75%C; 30 min: 
100%B; 45 min – 100%B). 
 
4.4.5 LCMS conditions for HBI synthase assays  
HPLC conditions - HPLC - 1260 series Agilent. LC-18 column -  ((Supelcosil LC-18-T 
column (15cm x 3mm, 3µm)). Following gradient was used - A: 5mM ammonium 
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formate, B: 75% methanol and 25% water. Following gradient was used - 0 min: 100% 
A; 7 min: 100% A; 25 min: 70% A, 30% B; 26 min: 100% B; 28 min – 100% B; 29 min: 
100% A; 40 min – 100%A). MS conditions for LCMS experiments - Capillary, -4500 V; 
Capillary offset, -500 V; Nebulizer gas, 3.0 bar; Dry gas, 10.0 L/min; Dry gas 
temperature, 200oC; Funnel 1 RF, 200.0 Vpp; Funnel 2 RF, 250.0 Vpp; ISCID, 0.0 eV; 
Hexapole RF, 200 Vpp; Quadrapole, Ion energy, 5.0 eV; Low mass, 100 m/z; Collision 
cell, collision energy, 10.0 eV; Collision RF, 150.0 Vpp, Transfer time, 100.0 µs; 
Prepulse storage, 5.0 µs. Data was processed with DataAnalysis ver. 4.0 SP4  
 
4.4.6 Synthetic scheme for AIRs (36)27 
The synthetic scheme for AIRs (36) is shown in Figure 4.12. Dr. Sameh H. 
Abdelwahed synthesized all the labeled AIRs isotopomers. 
 
            
 Figure 4.12: Synthetic scheme for AIRs (36). 
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4.4.7 Synthesis of methyl a/b-D-ribofuranoside (29) 
Methyl a/b-D-ribofuranoside (1.4 g, 8.5 mmol) was coevaporated twice with 
deuterium oxide (99.8 % atom D, 5.00 ml each) and dissolved in the same solvent (28 
ml), deuterated Raney-Ni (settled volume: 15 ml) was added with bubbling Argon 
through the mixture for 10 min. The reaction mixture was refluxed with stirring at 110oC 
in an oil bath for 7 days in an atmosphere of Argon. The mixture was filtered through 
celite, washed with water, and the combined aqueous phases were evaporated to give an 
oily product (0.52, 51%).1H NMR (acetone-d6 + D2O, 300 MHz) d 4.71(s, 1H), 3.55 (s, 
0.5H), 3.27 (s, 3H); 13C NMR (acetone-d6, 75 MHz) d 108.8, 103.4 (C1), 84.1 (C4), 
74.9 (t, J =23.1), 71.4 (t, J = 22.2 Hz), 62.5 (quintet, J = 20.4 Hz), 54.7. 
1H-NMR (D2O) (a): 4.92 (s, 1H) H-l; 4.02 (s, 0.3H) H-4; 3.37 (s, 3H) OCH3; (b) 4.83 
(s,1H) H-1; 3.93 (s, 0.7H) H-4; 3.33 (s, 3H) OCH3. 13C–NMR (D2O) (a): 103.5 C1; 
84.9 C4; 55.8 OCH3; (b): 108.3 C1; 83.1 C4; 55.52 OCH3. 
 
4.4.8 Synthesis of 1-O-Methyl-2,3,5-tri-O-acetyl-a/b-D-ribofuranoside (30) 
To a cooled (ice-bath) solution of 29 (0.3 g, 1.75 mmol) in anhydrous pyridine (5 
ml) acetic anhydride (0.5 ml, 564 mg, 5.48 mmol) was added with stirring. The stirring 
was continued for 4 hr. at room temperature. Usual work-up and drying gave a thick oil 
(0.4 g, 80%). (b): 4.87 (s,1H) H-1; 4.09 (d) H-4; 3.40 (s, 3H) OCH3; (a) 5.10 (s, 1H) H-
1; 4.29 (d) H-4; 3.37 (s,3H) OCH3; 2.11 - 2.06 (3xs, 9H) 3xOAc (a+b) 
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4.4.9 Synthesis of 1,2,3,5-tetra-O-acetyl-a/b-D-ribofuranoside (31) 
(0.4 g, 1.39mmol) of 30 was dissolved in glacial acetic acid (10ml) and acetic 
anhydride (1.4 ml, 1.56mmol) and treated with sulfuric acid (0.2 ml) with ice-cooling. 
After 3 h at room temperature, the solution was stirred with ice-water, extracted with 
chloroform, washed with water, then aqueous sodium hydrogen carbonate, dried over 
MgSO4 and evaporated to give compound 31 as pale yellow syrup (0.4 g, 92 %). 1H-
NMR of main components (CDC13): (b): 6.16 (s, 1H) H-1; 4.36 (s) H-4# (a): 6.42 (s, 
1H) H-1; 4.44 (s) H-4#; 2.2 -2.1 (4xs, 12H) 4xOAc (a+p). For mix of anomers : 1H 
NMR (CDCl3, 300 MHz) d 6.32, 6.06 (s, 1H), 4.34, 4.27 (s, 0.5 H), 2.07 (s, 3H), 2.01 (s, 
3H), 1.96 (s, 3H) 
 
4.4.10 Synthesis of 5-nitro-1-(2,3,5-tri-O-acetyl-b-D-ribofuranoside (34) 
To a solution of  31 (0.4 g, 1.26 mmol) in dichloromethane (5 mL) at -76oC, 
bromotrimethylsilane (1.5 mL, 10.9 mmol) was added dropwise and the temperature was 
allowed to rise to room temperature overnight. Bromo trimethylsilane and trimethylsilyl 
acetate were removed in vacuo at 20oC. The crude product was dissolved in 5 mL of dry 
xylene. This solution was then added dropwise to a mixture of the silver salt of 4- 
nitroimidazole (0.5 g, 2.2 mmol) in xylene (12 mL) at reflux. The reaction mixture was 
refluxed for 1 h, cooled, and filtered. The solvent was evaporated in vacuo (45 °C bath) 
and the residue dissolved in 10 mL CHCl3. The solution was washed (NaHCO3, H2O), 
dried (MgSO4), and concentrated. The product was purified by flash column 
chromatography (1 : 1 ethyl acetate : hexanes) to give 120 mg of a colorless oil 
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(26%).1H NMR (CDCl3, 300 MHz) d 8.11 (s, 1H), 8.04 (s, 1H), 6.45 (s, 1H), 4.48 (s, 
0.5H), 2.17 (s,3H), 2.16 (s, 3H), 2.06 (s, 3H). 
 
4.4.11 Synthesis of 5-nitro-1-(-b-D-ribofuranoside)imidazole (35) 
34 (120 mg, 0.32 mmol) was dissolved in methanol (2 mL), and water (0.8 mL) 
and triethylamine (0.8 mL) were added. The mixture was stirred for 12 h at room 
temperature and the solvent was removed in vacuo. The residue was dissolved in 2 mL 
of water and lyophilized to provide 80 mg (99%) of a pale yellow oil. 1H NMR (MeOD, 
300 MHz) d 8.54 (s, 1H), 7.91 (s,1H), 6.20 (s, 1H), 3.98 (s, 0.5H). 
 
4.4.12 Synthesis of 5-amino-1-(-b-D-ribofuranoside)imidazole (36) 
35 (80 mg, 0.33 mmol) was dissolved in anhydrous methanol (30 mL). 30 mg of 
10% Pd/C was added and the mixture was hydrogenated at atmospheric pressure and 
room temperature for 3 h. The catalyst was removed by filtration and solvent removed in 
vacuo to give a colorless oil (100%). 1H NMR (D2O, 300 MHz) d 7.60 (s, 1H), 6.43 (s, 
1H), 5.66 (s, 1H), 4.12 (s,0.5H) 
C-labeled AIR analogs: [1'-13C]AIRs and [3'-13C]AIRs were made from [1-
13C]ribose and [3-13C] ribose respectively by the same procedure described above and 
then enzymatic phosphorylated.  
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5. SUMMARY AND OUTLOOK 
 
5.1 Summary 
The studies presented in this dissertation provide insightful details in the early 
steps of molybdopterin biosynthetic pathway. Mechanistic details of the complex radical 
rearrangement reaction catalyzed by MoaA were elucidated.38,41,45 Studies on thiamin 
pyrimidine synthase, ThiC resulted in the completion of product labeling studies. 
Bioinformatics investigations on ThiC resulted in the identification and first report of the 
in vitro reconstitution of the elusive benzimidazole biosynthesis in the anaerobic vitamin 
B12 biosynthetic pathway.  
 
5.1.1 Molybdopterin biosynthesis 
The genes responsible for molybdopterin biosynthesis have been known since 
1980s. However, the chemical details of the early steps of this biosynthetic pathway 
were yet to be elucidated.32 The biosynthesis of molybdopterin is similar in plants, 
animals and microorganisms. The first steps in the molybdopterin biosynthesis are 
catalyzed by MoaA and MoaC use guanosine-5'-triphosphate (1; GTP) as the precursor 
to synthesize cyclicpyranopterinmonophosphate (cPMP). Previous labeling studies had 
established that in the conversion of GTP to cPMP by MoaA-MoaC, the C8 of GTP is 
inserted between the C2’ and C3’ carbons. This is an unprecedented reaction catalyzed 
in ribose chemistry. Also, it was shown that MoaA is a member of the radical-SAM 
superfamily of proteins and harbors two [4Fe-4S]2+,1+ clusters. The N-terminal [4Fe-4S] 
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cluster is likely to be responsible for the reductive cleavage of SAM to the 5’-
deoxyadenosyl (5’-dA) radical and L-methionine and the second cluster binds to N1 of 
GTP. A 2.35 Å crystal structure of MoaA shows the two clusters at the active site as well 
as the orientation of 5’-deoxyadenosine (5’dA) as compared to GTP.29-31 
We demonstrated that MoaA catalyzes the first step in molydopterin biosynthesis 
where guanosine-5’-triphosphate (GTP, 1) is converted to pterin (15, Figure 5.1).41 
Meanwhile, a study from Kenichi Yokoyama’s lab suggested that (4) was the product of 
MoaA.44 We expressed MoaA in E. coli (MoaC-) and showed that we formed pterin as 
the product of MoaA. This provided the first conclusive evidence that pterin (15) was the 
product of MoaA. Thus, we demonstrated that MoaA catalysis involves a remarkable 
rearrangement reaction where the C8 of GTP is inserted between the C2’ and C3’ carbon 
atoms of GTP to give the final pterin (15).41  
To get mechanistic insights in to the MoaA-catalyzed chemistry, we identified  
the position of hydrogen atom abstraction by 5’-deoxyadenosyl radical.  We used 2’,3’-
dideoxyGTP as a substrate analog and trapped a novel intermediate (27). We further 
trapped the radical (2) by using 2’-chloroGTP. We characterized the products of MoaA 
reaction with 2’-chloroGTP. 41 
We decided to explore the use of 2’-deoxyGTP to probe the later steps of the 
reaction. MoaA reaction with 2’-deoxyGTP resulted in the formation of a stero-specific 
product pterin. This suggested that the formation of this pterin was primarily or 
exclusively occurring at the MoaA active site because non-enzymatic chemistry would 
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result in the scrambling of stereochemistry at C3 of the pterin substituent. This study 
clarified the later step of MoaA-catalyzed transformation.  
Based on all these studies we revised our mechanistic proposal for the MoaA-
catalyzed reaction (as outlined in Figure 5.1)41 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.1: Mechanistic proposal for MoaA-catalyzed transformation 
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AIR (unpublished). At some point during the reaction, 5’dA transfers the hydrogen atom 
on to AIR derived intermediate, which eventually forms HMP-P. The HMP-P 
stereochemistry demonstrates that this hydrogen atom abstraction occurs from the si face 
of the radical resulting in overall retention of stereochemistry for the C5’ hydrogen atom 
replacement reaction. 
We performed several active-site mutant studies with a view to trap and 
characterize intermediates in the ThiC catalyzed reaction. In case of some of the 
mutants, AIR derived intermediates can be detected. However, trace levels of products 
are formed thus making it impossible for complete NMR characterization of these 
products. 
  
5.1.3 Anaerobic vitamin B12 biosynthesis – hydroxybenzimidazole 
biosynthesis  
 In our pursuit to study the mechanistic details of the ThiC catalyzed 
transformation, we decided to investigate ThiC homologs from different organisms that 
work better or catalyze different, more tractable chemistry. Bioinformatics search for 
thiamin biosynthetic genes (in particular ThiC) in the SEED database 
(http://theseed.uchicago.edu/FIG/index.cgi) revealed that there are several 
microorganisms that have more than one copies of ThiC. From the set of organisms that 
have multiple copies of ThiC, we observed that there is a subset of organisms where one 
of these copies of ThiC (which we named as ThiC*) was clustered with vitamin B12 
biosynthetic genes. Also, many of these organisms are listed as anaerobic 
 	   116 
microorganisms. Anaerobic biosynthesis of vitamin B12 has been extensively studied.62-
69,71,72 However, the gene product(s) responsible for the biosynthesis of the “lower 
ligand” of vitamin B12 – dimethylbenimidazole was (were) unknown. 
We identified and reconstituted hydroxybenzimidazole synthase (HBI synthase) 
involved in vitamin B12 biosynthesis has solved an old and important puzzle in the 
anaerobic vitamin B12 biosynthesis. Our studies suggested that AIR was a direct 
precursor to 5-HB. This was consistent with the previous studies as D-erythrose is the 
precursor to ribose-5-phosphate. Also, glycine is a substrate of the 
phosphoribosylamine-glycine ligase, an enzyme on the AIR biosynthetic pathway 
(purine metabolism).  
Several site-specifically isotopically labeled AIR were used to study the labeling 
pattern on 5-HB and 5’-dA. Based on these studies, we advanced a mechanistic proposal 
consistent with our studies so far. 
The mechanistic proposal for HBI synthase-catalyzed transformation is shown in 
Figure 5.2 
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Figure 5.2: Mechanistic proposal for HBI synthase-catalyzed transformation 
 
5.2 Outlook 
Based on all our studies, my general opinion is that the critical step to study 
radical AdoMet enzymes is the robust reconstitution of [4Fe-4S] cluster and protein 
activity. This, to me, is the “corner stone” to proceed for performing mechanistic and 
structural studies on these enzymes. 
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5.2.1 Molybdopterin biosynthesis - crystallography 
The crystal structure (2FB3) is not a particularly high-resolution structure 
(2.35A). For example, the binding of the purine to the second iron sulfur cluster has been 
shown by Hoffman group using ENDOR spectroscopy to be incorrect. In addition, the 
binding site for the deoxyadenosine makes no sense in the context of a deoxyadenosyl 
radical abstracting a hydrogen atom from C3’ of GTP. Therefore, it seems that the 
MoaA structure is not yet at the level where we can reliably predict residues involved in 
catalysis. High-resolution structure with GTP and SAM/SAH bound will be highly 
informative. 
 
5.2.2 Thiamin pyrimidine synthase – ThiC – trapping of organic radicals 
Rapid freeze quench followed by high-field EPR studies have been recently used 
by the Britt Lab to study organic radicals generated in the radical AdoMet enzymes.23,75 
In our lab, we also have the synthetic expertise to make site-specifically labeled AIR 
isotopomers and make highly quality ThiC. With all these technical expertize, rapid 
freeze quench followed by high-field EPR studies seems to be a promising tool to study 
ThiC catalyzed chemistry. 
 
5.2.3 Testing HBI synthase homologs– anaerobic vitamin B12 biosynthesis 
With a view to find a more robust HBI synthase homolog for crystallographic 
studies, it may be of value to screen HBI synthase homologs from different organisms. 
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5.2.4 HBI synthase – EPR studies 
Rapid freeze quench followed by high-field EPR studies seems to be a promising 
tool to study HBI synthase catalyzed chemistry. Kinetic studies on HBI synthase are 
recommended before performing the EPR studies. 
 
5.2.5 AIR analogs to study HBI synthase and ThiC reactions 
Using substrate analogs has been significantly useful to elucidate the mechanistic 
details of MoaA catalyzed transformation.38,41,45 Testing AIR analogs with a view to trap 
out intermediates in the ThiC and HBI synthase reactions may be highly informative. 
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APPENDIX 
 
The appendix describes a summary of ThiC activity studies with substrate 
analogs. We tested several ThiC substrate analogs with a view to trap ThiC-reaction 
interemediates. Figure A1 demonstrates the substrate analogs that were tested. However, 
no/trace levels of products were detected in these reactions making it impossible for 
complete NMR characterization of the products formed. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure A1: Substrate analogs that were tested for ThiC-catalyzed reactions. 
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